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Abstract 
During Drosophila melanogaster pupation, groups of undifferentiated adult cells 
proliferate and undergo regulated cell shape changes, while larval tissues are eliminated by 
programmed cell death (PCD). PCD is most commonly associated with apoptosis; however, a 
growing body of evidence suggests that autophagic cell death represents an alternative form 
of PCD. In some contexts autophagy can induce caspase-dependent PCD, but the regulatory 
pathways that link autophagy and apoptosis remain poorly understood. The overexpression of 
Atg16B induces autophagy-dependent caspase activation in the larval epidermis, and 
presumptive adult tissues. Also, the overexpression of Atg16B, in tissues specified by 
pnrGAL4, results in an adult cuticular phenotype that cannot be directly attributed to caspase 
activity. However, altering the level of Atg16B expression can modulate the adult cuticular 
phenotype. Therefore, the adult cuticular phenotype was used in a broad based genome-wide 
screen for dose-dependent modifiers of the regulation of autophagy. To date, 399 
chromosomal deficiencies, representing approximately 92% of the 2nd and 3rd chromosomes, 
and 25 duplications have been tested. Consequently, 42 deficiencies have been identified as 
dominant enhancers of the Atg16B overexpression phenotype, 24 deficiencies have been 
identified as dominant modifiers, and 13 deficiencies have been identified as dominant 
suppressors. Further genetic analysis of these interacting deficiencies was carried out to 
initiate the process of identifying individual loci associated with the dose-sensitive 
modification of the Atg16B overexpression phenotype. It is hoped that the identification of 
these genes will elucidate the genetic pathways regulating autophagy and the autophagic 
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Chapter 1. Introduction 
1.1 Programmed Cell Death 
Cell death can be divided into two categories: Programmed Cell Death (PCD) and 
Necrosis. Necrosis is an uncontrolled form of cell death that results when cells are 
accidentally injured by mechanical damage, exposure to toxins, or pathogenic infection (Van 
Cruchten and Van Den Broeck, 2002).  In contrast, PCD is a genetically regulated process 
that is frequently used to remove superfluous cells and tissues during animal development 
(Mohseni et al., 2009). Furthermore, PCD is controlled through three distinct PCD initiating 
pathways: apoptosis, autophagy, and non-lysosomal cell death (Luo et al., 2007).  Typically, 
apoptotic and autophagic cell morphologies are observed in cells that are destined to die 
during development. In contrast, non-lysosomal cell death is rarely observed during 
development, and is identified by swollen organelles and the lysosome-independent formation 
of ‘empty spaces’ in the cytoplasm (Baehrecke, 2005).  
1.1.1 Apoptosis 
Apoptosis, the most recognized form of PCD, is often described as a “suicide” 
program that, when activated, leads to the death of individual cells by caspases, a family of 
site specific proteases (Alberts et al., 2008). Apoptosis, or caspases, can be activated in two 
distinct ways: extrinsically and intrinsically. The extrinsic pathway is activated by the binding 
of extracellular signal proteins to death receptors on the surface of the cell, whereas the 
intrinsic pathway is triggered by signals from inside the cell in response to a loss of inner 
mitochondrial membrane potential. Two groups of caspases are activated in response to the 
extrinsic and intrinsic pathways: the initiator caspases and the executioner caspases. The first 
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caspases to be activated in response to the extrinsic and intrinsic pathways are the initiator 
caspases. Upon activation, the initiator caspases cleave and activate many downstream 
executioner caspases, resulting in a proteolytic caspase cascade (Alberts et al., 2008). 
Ultimately, this proteolytic cascade results in the cleavage of various protein substrates by 
executioner caspases, which results in a characteristic morphology that includes: cell 
shrinkage, nuclear fragmentation, cytoskeleton collapse, and membrane blebbing (Alberts et 
al., 2008). Also, the cell membrane of an apoptotic cell changes its chemical composition 
through the exposure of phosphatidylserine on the outer leaflet of the lipid bilayer, signaling 
neighboring cells or macrophages to engulf the apoptotic corpse (Baehrecke, 2005).  
 
Figure 1.1: The apoptosis PCD Pathway in Drosophila melanogaster. Normally, the H99 
genes: grim, reaper and hid inhibit DIAPs. The inhibition of DIAPs allows the activation of 
caspases. Caspase activation results in apoptosis. p35 inhibits caspases, preventing apoptosis. 
Proteins in green inhibit apoptosis. Proteins in blue stimulate apoptosis. 
 
To prevent the inappropriate activation of caspases and subsequently apoptosis, cells 
possess Inhibitor of Apoptosis Proteins (IAPs). Normally, IAPs bind to and inhibit 
inappropriately activated caspases, preventing the proteolytic cascade that would ultimately 
result in a cell’s demise. In Drosophila, IAPs (DIAPs) are targeted for proteolytic degradation 
during an apoptotic response by the products of the so-called H99 genes: head involution 
defective (hid), grim, and reaper (rpr) (Bangs et al., 2000).  The downregulation of DIAPs 
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allows caspase activation and thereby promotes apoptosis (Figure 1.1).  In principle, this 
highly regulated pathway should prevent the inappropriate activation of apoptosis. Many 
viruses, however, express genes that target this pathway in order to prevent host cells from 
entering apoptosis. The baculovirus caspase inhibitor, p35, when expressed in Drosophila, 
acts as a suicide inhibitor or “Trojan horse” destroying itself upon irreversibly inactivating 
caspases (Figure 1.1) (Tschopp et al., 1998).  
1.1.2 Autophagy  
Unlike apoptosis, which is synonymous with PCD, autophagy represents a catabolic 
process that functions in many cellular and biological processes (Berry and Baehrecke, 2007). 
Autophagy occurs as a normal cellular response to starvation, and acts a mechanism for the 
turnover of organelles and the clearance of protein aggregates (Klionsky and Emr, 2000). 
Also, autophagy can, in certain contexts, function as a pro-death mechanism (Levine and 
Yuan, 2005; Tsujimoto and Shimizu, 2005; Mohseni et al., 2009). Given that autophagy is 
often employed as a cellular response to starvation, and is therefore considered a pro-survival 
mechanism, the role of autophagy in PCD seems paradoxical (Tsujimoto and Shimizu, 2005). 
In particular, it is often debated whether autophagy functions as an independent cell death 
pathway, acts to promote apoptosis, or represents a failed attempt to suppress cell death 
(Tsujimoto and Shimizu, 2005; Mohseni et al., 2009; Scott et al., 2007; Berry and Baehrecke, 
2007). 
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1.1.2.1 The Process of Autophagosome Formation: An Overview 
In response to starvation or other inductive cues, autophagosomes, double membrane 
vesicles that engulf cytoplasmic elements, are formed (Klionsky, 2004). 
 
 
Figure 1.2: Diagram illustrating the various steps in the formation of the autophagosome and 
autolysosome (Adapted from Pattingre et al., 2008). 
 
 The autophagy related proteins, Atg1, Atg5, Atg8, and Atg12 are essential for the 
formation of autophagosomes. Upon the initiation of autophagy, Atg12 is attached to Atg5, 
forming the Atg12-Atg5 complex. This complex is required for the localization of Atg8 to the 
isolation membrane. It is thought that the localization of Atg8 to the isolation membrane 
contributes to its elongation. As the isolation membrane elongates and closes to form the 
autophagosome, it sequesters cytoplasm and organelles. Upon autophagosome formation, the 
Atg12-Atg5 complex is lost from the autophagosomal membrane (Rusten et al., 2004). 
Afterwards, the autophagosome fuses with a lysosome, resulting in the breakdown of Atg8, 
the inner autophagosomal membrane, and any sequestered material (Figure 1.2) (Pattingre et 








degraded by the lysosome, Atg8 is widely used as a marker of autophagosomes (McPhee and 
Baehrecke, 2009). 
1.1.2.2 Atg1 Is A Key Regulator of Autophagy 
Atg1, a conserved serine/threonine-specific protein kinase, appears to be a key 
regulator of multiple steps in the autophagic process (Scott et al., 2007). Recent studies have 
shown that Atg1 is involved in the initiation and execution of autophagosome formation, and 
the shuttling of proteins into and out of the autophagosomal membranes (Pattingre et al., 
2008; Reggiori et al., 2005). Furthermore, it has been shown that Atg1 is a target of the 
InR/PI3K and TOR signaling pathways (Figure 1.3) (Stephan and Herman, 2006; Scott et al., 
2007). The interaction between TOR and Atg1 is particularly interesting since TOR is also a 
target of Atg1 through a self-reinforcing negative feedback loop (Figure 1.3) (Neufeld, 2007; 
Neufeld and Baehrecke, 2008). It has been speculated that it is the mutual antagonism 
between Atg1 and TOR that ultimately regulates autophagy (Neufeld, 2007). Determining the 
mechanisms regulating autophagy is important since it is speculated that low levels of 
autophagy can be cytoprotective, whereas high levels of autophagy result in the activation of 
PCD (Scott et al., 2007). Revealing the substrates of Atg1, which are currently poorly 
defined, may elucidate the mechanisms involved in controlling the various cellular and 
biological processes of autophagy. 
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Figure 1.3:  Nutritional and developmental control of Autophagy. Upon activation, the insulin 
receptor (InR) activates phosphatidylinositol-3 kinase (PI3K) which leads to the activation of 
protein kinase B (PKB)/Akt.  An increase in TOR activity results in the inhibition of Atg1 and 
autophagy levels decrease. Ecdysone Receptor negatively regulates PI3K, resulting in an 
increase in autophagy. Prolonged increases in autophagy can lead to cell death (Neufeld and 
Baehrecke, 2008). Proteins and steroids that stimulate autophagy are colored in blue. Proteins 
that inhibit autophagy are colored in green. 
 
1.1.2.3 Autophagy and Cell Survival 
 A relationship between cell survival and autophagy has been observed during 
Drosophila development. Normally, when nutrients are plentiful TOR (Target Of Rapamycin) 
signaling is active, and autophagy proceeds at a basal level. Under these conditions, 
autophagy functions to maintain homeostasis through the removal of defective or superfluous 
organelles, and abnormal or damaged proteins (Meléndez and Neufeld, 2008). Conversely, 
under nutrient limiting conditions, a decrease in the activity of Insulin/PI3K or TOR signaling 
pathways results in an increase in the level of autophagy. At increased levels, autophagy 
functions to promote cell survival by supplying the cell with energy and nutrients such as 
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methylpyruvate, a mitochondrial substrate of the tricarboxylic acid cycle (Lum et al., 2005) 
and amino acids, building blocks for the synthesis of new proteins (McPhee and Baehrecke 
2008). Therefore, a basal level of autophagy is essential to maintain homeostasis and 
autophagy is upregulated under starvation conditions to promote survival. Since autophagy is 
a catabolic process, prolonged induction of this process can decrease cell growth and deplete 
energy and nutrient supplies, ultimately leading to cell death (Neufeld and Baehrecke, 2008; 
Debnath et al., 2005; Berry and Baehrecke, 2007). Therefore, autophagy can promote cell 
survival but should be carefully regulated as prolonged autophagic induction can also lead to 
cell death.  
1.1.2.4 Autophagic Cell Death 
Autophagic (Type II) cell death describes a form of cell death that results from 
excessive levels of autophagy and occurs primarily during development when cell death 
occurs en masse (Levine and Yuan, 2005). Sometimes described as “histolysis”, autophagic 
cell death is distinguished from apoptosis through many of its distinct morphological features. 
In general, the morphological characteristics of autophagic cell death include, an abundance 
of autophagosomes and autolysosomes, early organelle degradation, late cytoskeletal 
disassembly and chromatin condensation, and finally DNA fragmentation (Shimizu et al., 
2004; Yu et al., 2004; Levine and Yuan, 2005; Lockshin and Zakeri, 2004). Also, autophagic 
cell death occurs largely in the absence of macrophages, since dying cells are degraded by 
their own lysosomal enzymes rather than by phagocytosis (Lee and Baehrecke, 2001; Martin 
and Baehrecke, 2004).  
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Figure 1.4: Model diagram of autophagic cell death, illustrating the parallel relationship that 
occurs between autophagy and apoptosis during salivary gland histolysis. Elevated levels of 
ecdysone result in caspase activation and a dramatic increase in autophagy. Each PCD 
pathway is activated by ecdysone but act independently to promote salivary gland histolysis. 
 
During metamorphosis, a rise in the steroid hormone 20-hydroxyecdysone (ecdysone) 
triggers the autophagic destruction of obsolete larval structures. Ecdysone signaling has been 
found to be involved in larval tissue histolysis through a negative interaction with PI3K 
(Figure 1.3) (Rusten et al., 2004). The inhibition of the InR/PI3K pathway, through ecdysone 
signaling, results in the dramatic increase in autophagy and subsequent autophagic 
degradation of larval tissues (Rusten et al., 2004; Lee and Baehrecke, 2001; Martin and 
Baehrecke, 2004; Berry and Baehrecke, 2007). Although these larval tissues are largely 
eliminated by autophagic cell death, some hallmarks of apoptosis have been observed. The 
observation of both apoptotic and autophagic morphologies indicate that these PCD pathways 
can act cooperatively during larval tissue histolysis (Berry and Baehrecke, 2007; Scott et al., 
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2007; Pattingre et al., 2007). In particular, studies of larval salivary gland histolysis have 
shown that a rise in ecdysone during metamorphosis induces the transcription of hid and rpr, 
two of the pro-apoptotic H99 genes (described in Section 1.1.1)(Jiang et al., 1997; Lee et al., 
2000; Yin and Thummel, 2004). Additionally, it has been shown that the complete destruction 
of Drosophila salivary glands requires autophagy and caspase activation (Lee and Baehrecke, 
2001). However, the relationship between the apoptotic and autophagic cell death pathways, 
in this context, is parallel with both pathways acting on salivary gland histolysis 
independently (Figure 1.4)(Lee and Baehrecke, 2001; Berry and Baehrecke, 2007). In other 
tissues, the role of autophagy and its relationship with caspase activation can change 
depending on the organism, cell type, and cell-specific conditions (Baehrecke, 2005). 
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1.1.2.5 Autophagy-Dependent Caspase Activity 
 
Figure 1.5: Model diagram of autophagy-dependent caspase activation, illustrating that low 
levels of autophagy promotes cell survival and high levels of autophagy, through the 
overexpression of Atg1, results in autophagy-dependent caspase activity and ultimately cell 
death. In this model the relationship between caspase activation and autophagy is epistatic. 
 Recently, “autophagy-dependent caspase activation” was coined as a term to describe 
a type of caspase-dependent cell death that is induced by high levels of autophagy (Mohseni 
et al., 2009). Unlike autophagic cell death, which acts as an independent cell death pathway, 
autophagy-dependent caspase activation employs a single pathway whereby high levels of 
autophagy act to induce caspases and subsequently apoptosis (Figure 1.5). Although the 
mechanisms regulating this pathway remain unknown, a recent study has shown the existence 
of autophagy-dependent caspase activity during Drosophila development. An article by 
Mohseni et al., which includes data from this thesis, illustrates that the upregulation of 
autophagy in the amnioserosa (AS), an extra-embryonic epithelial tissue, results in a caspase-
dependent cell death (2009) (For more information on AS degeneration during dorsal closure 
(DC) see Appendix A – Section A.2).  In this study, it was demonstrated that the complete 

















Also, it was established that, during the elimination of the AS, autophagy is required for 
caspase-activation; however, autophagy continues unabated in mutants defective in the 
activation of apoptosis (Mohseni et al., 2009; Reed Lab Unpublished Data). Together, these 
results suggest that autophagy acts upstream of caspase-activation during the elimination of 
the AS (Figure 1.5).  
In another study, Scott et al., have demonstrated that the overexpression of Atg1 in 
patches of the imaginal wing disc results in the induction of autophagy-dependent caspase-
activation (2007) (For more information on the development of the wing disc see Appendix A 
– Section A.3). This induction of cell death is rescued by an Atg8 mutant background (Scott et 
al., 2007), demonstrating the requirement of an intact autophagy pathway for the induction of 
caspases. This study also reported that the co-expression of p35 was able to delay the death of 
Atg1-overexpressing patches in the wing-disc (Figure 1.5) (Scott et al., 2007). Similarly, one 
of the findings reported in this thesis is that an increase in autophagy, through the 
overexpression of Atg1 in the proximal area of the wing disc, results in a caspase-mediated 
cell death, and this cell death can also be rescued by the co-expression of p35 (Figure 1.5). 
Together, these results suggest that an increase in autophagy via Atg1 overexpression, in this 
context, results in the promotion of cell death directly through caspases rather than autophagy 
acting as a distinct form of cell death. 
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1.1.2.6 Interpretation: Autophagic Cell Death and Autophagy-Dependent Caspase 
Activation 
The most parsimonious interpretation of the literature is that the role of autophagy, be 
it pro-death or pro-survival, is context or tissue dependent. Although it has been shown that 
nutrient conditions, developmental signaling, and TOR expression levels all regulate 
autophagy, it is unknown whether these factors may be implicated in the decision to undergo 
an autophagy-induced cell death (Neufeld and Baehrecke, 2008). Consequently, further 
research should be conducted to determine what mechanisms are involved in the regulation of 
both PCD pathways in Drosophila. 
1.1.2.7 Why Study Autophagy in Drosophila melanogaster? 
Understanding the regulation of autophagy and its relationship with PCD is important 
since it is closely associated with human health and disease. For example, various human 
neurodegenerative diseases including Huntington’s chorea, Alzheimer disease, and 
Parkinson’s Syndrome are associated with aggregate-prone proteins (Sarkar et al., 2008). 
While low levels of autophagy may be beneficial in clearing cells of these pathogenic protein 
aggregates (Sarkar et al., 2008), high levels of autophagy are thought to induce apoptosis 
(Klionsky, 2007; Scott et al., 2007; Mohseni et al., 2009). Since increased rates of apoptotic 
neuronal cell death leads to the progression of these debilitating diseases, a better 
understanding of the mechanisms regulating autophagy is required before agents that 
manipulate autophagy, such as rapamycin, are used as a therapy for neurodegenerative 
disorders (Sarkar et al., 2008),  
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1.2 Main Experimental Objectives: 
The first objective of this study involves the development of an in vivo method for the 
detection of autophagy in the amnioserosa (AS), an extraembryonic membrane, during 
Drosophila embryogenesis. The data presented here demonstrates that the onset and 
disruptions of autophagy can be detected using the vital dye lysotracker. Also, it has been 
shown that autophagy proceeds in backgrounds that lack caspase activity.  
The second objective is to address the relationship between autophagy and caspase 
activation. The approach presented here involves the development of an in vivo method 
(Apoliner) for detecting caspase activity. This method is applied to a variety of tissues during 
Drosophila development including the AS, dorsal larval epidermis and presumptive adult 
tissues (for more information on the developmental events associated with these tissues, see 
Appendix A). Together, the data here confirms that autophagy can induce caspase activation 
in the context of the AS, as well as the third instar larval epidermis and wing disc.  
It is also presented in this thesis that the overexpression of Atg16B results in an adult 
cuticular phenotype that is not directly associated with caspase activity. Nonetheless, altering 
the level of Atg16B expression can modulate this adult cuticular phenotype. The third and last 
objective is the design and execution of a genetic screen to identify dose-sensitive modifiers 
associated with the induction of autophagy by ectopic Atg1 kinase expression.  
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Chapter 2. Materials and Methods  
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Chapter 2. Materials and Methods 
2.1 Fly Strains and Handling 
Flies were raised on standard Drosophila medium at 25°C unless otherwise stated. 
Detailed descriptions of the [UAS-Atg16A], [UAS-Atg16B], [LP1-GAL4], [yw67], [(UAS-
GFPnls)8], [UAS-p35], [UAS-Apoliner], [Yet1; LP1-GAL4], [UAS-p35; UAS-p35] stocks can 
be found in Mohseni et al., 2009. Deficiencies, duplications, and mutations utilized in the 
enhancer and suppressor screen were obtained from Bloomington Drosophila Stock Center or 
Dr. Tony Harris and Dr. Craig Smibert at the University of Toronto. Complete genotype 
notations for all stocks are available online at FlyBase (http://flybase.bio.indiana.ed/). For a 
complete list of the stocks used in the enhancer and suppressor screen see Appendix D. 
2.2 GAL4-UAS Inducible Gene Expression System 
The GAL4-UAS inducible gene expression system was used to express a variety of 
genes at different stages and in different tissues during Drosophila development. To express 
genes of interest using the GAL4-UAS system, a genetic cross is performed between a GAL4 
transcription factor bearing stock (the “driver”), and a stock carrying a gene with an upstream 
activating sequence (UAS)(the “reporter”). In progeny that contain both the driver and 
reporter, genes of interest are expressed in the tissue specified by the driver (Hartwell et al., 
2000). Drivers that were used in the following experiments include the AS-specific LP1-
GAL4 and pnrGAL4, a driver that enables ectopic gene expression in a medial-dorsal stripe 
throughout development. Additionally, this system was used to alter the level of ectopic gene 
expression throughout development. Increasing the temperature from 25ºC to 29ºC increases 
the level of GAL4 expression, while decreasing the temperature from 25ºC to 18ºC decreases 
the level of GAL4 expression (Armstrong et al, 2006). 
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2.3 GAL80  
In the GAL4-UAS system, Gal4 is expressed in a defined set of cells as specified by a 
tissue-specific enhancer, or other regulating sequences. GAL80 suppresses GAL4 activity by 
binding to the activation domain of GAL4, inhibiting the ability of GAL4 to bind to the UAS 
sequences. Expressing Gal80 with a tubulin promoter results in the global suppression of 
GAL4 activity (McGuire et al., 2003).  
2.3.1 GAL80ts 
GAL80ts is a temperature-sensitive version of the previously mentioned GAL80 
protein. In this system, the temperature-sensitive GAL80 protein is expressed ubiquitously 
from the tubulin promoter at 19°C, thereby repressing the transcriptional activity of GAL4. 
However, GAL80ts is rendered inactive at 30°C, allowing GAL4 to drive the expression of the 
gene of interest in cells specified by the tissue-specific driver (McGuire et al., 2003). 
2.3.2 GAL80ts Experiment 
 Twenty-four vials, containing pnrGAL4+UAS-Atg16B/TM6,Tb[GAL80] females 
crossed to w*; P[tubP-GAL80ts]; TM2/TM6B,Tb1 males, were set up. In each vial, adults 
were allowed to mate and lay embryos for 24 hours. After 24 hours, adults were removed and 
the resulting progeny were allowed to develop. At various time-points during development, 
each vial was shifted once, either upwards, from 18°C to 29°C, or downwards, from 29°C to 
18°C. Once eclosed, the severity of the thoracic cleft and the reduced scutellum phenotype of 
[GAL80ts]/+; pnrGAL4+UAS-Atg1/TM2 or TM6B progeny were evaluated. Any consistent 
difference (enhancement or suppression of thoracic cleft and reduced scutellum phenotype) 
was noted (for more information on the life cycle and developmental processes associated 
with development See Appendix A1-4). 
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2.4 Embryo Collection 
Embryos were collected on juice agar plates in three-hour intervals at 25ºC or 29ºC 
using an automated Drosophila egg collector (Flymax Scientific Equipment Ltd.). Using PBT 
(0.1% Triton X-100 in 1x PBS), embryos were washed from the plates, collected in a nylon 
mesh basket, and washed with a copious amount of PBT and distilled water (Wieschaus and 
Nusslein-Volhard, 1986). 
2.5 Dechorionation 
The dechorionation technique varied depending on the experiment. Embryos being 
prepared for live imaging were dechorionated as follows: embryos were rolled gently on non-
toxic sticky tape with forceps. The chorion adheres well to the sticky tape while the vitelline 
membrane beneath the chorion does not, allowing for the removal of the chorion (Ashburner, 
1989). Alternatively, for lysotracker staining, embryos were collected in a nylon mesh basket 
and placed in 50% bleach, 50% PBT for 3 minutes. After 3 minutes, embryos were washed 
with copious amounts of water (Wieschaus and Nusslein-Volhard, 1986). 
2.6 Lysotracker Staining 
10-17-hour old embryos were collected and dechorionated as previously mentioned. 
Dechorionated embryos were transferred to a glass vial containing a 1:1 mixture of heptane 
and lysotracker solution (2µl of 1mM Lysotracker stock solution in 50mL of 0.7% NaCl 
Solution). Embryos were then shaken lightly for ten minutes. Afterwards, the aqueous phase 
(lysotracker solution) of the mixture was removed and replaced with heptane. Embryos were 
then collected in a nylon mesh filter and mounted on a confocal imaging chamber (See 
Section 2.7.1).   
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2.7 Live Imaging 
2.7.1 Confocal Live Imaging 
Embryos of interest were collected and dechorionated, as previously mentioned. In order 
to prevent desiccation after dechorionation, all embryos were immediately mounted on a 
confocal imaging chamber in gas permeable halocarbon oil (Methods for live imaging 
embryos are described in detail in (Reed et al., 2004; Reed et al., 2009)). The Zeiss Axiovert 
100 confocal microscope and LSM 510 software were used to capture all Lysotracker images. 
All other confocal images were captured using the Nikon Eclipse Confocal Microscope and 
EZ-C1 software. All images were processed using ImageJ software 
(http://rsb.info.nih.gov/ij/). 
2.7.2 Stereomicroscopic Live Imaging:  
2.7.2.1 Larval Preparation: First to third instar larvae were removed from 
Drosophila medium and placed on a steel filter. Larvae were then washed with a copious 
amount of water and placed in an embryo dish. 1x PBS was added to the embryo dish and 
larvae were chilled at 4°C for 1 hour. Halocarbon oil was chilled in ice for 30 minutes prior to 
imaging. After 1 hour, larvae were mounted on a slide with chilled Halocarbon oil and single 
surface images were taken.  
2.7.2.2 Pharate Adult Preparation: Pharate Adults were gently removed from vial 
walls, washed with water, and dried on a kim-wipe to clean the pupal case. Pharate adults 
were placed, dorsal-side up, on a slide.  Surface photographs were taken every 6 minutes for 
approximately three to four days. Movies were compiled using ImageJ software. A Leica MZ 
16 FA stereomicroscope and Leica Application Suite software were used for all larval and 
pupal live imaging.  
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2.7.2.3 Pharate Adult Dissection and Imaging: Pharate adults were removed from 
vials and washed as mentioned above (See Section 2.7.2.2). Pharate adults were placed 
dorsal-side up on double-sided sticky tape. Using forceps, the operculum was removed 
exposing the head of the pharate adult. Afterwards, the rest of the pupal case is peeled away 
leaving an intact pharate adult. Pharate adults were then placed on a slide in halocarbon oil 
and single surface images were taken. 
2.8 Scanning Electron Microscopy 
 Adult Drosophila were anesthetized with carbon dioxide and their wings were 
removed with forceps. These flies were placed in a glass vial containing 70% acetone for 1 
hour (within this hour the 70% acetone was changed 1x after thirty minutes). After 1 hr, the 
70% acetone was replaced with 95% acetone and left for another hour (within this hour, the 
95% acetone was changed 2 times). Finally, the flies were immersed in 100% acetone for 30 
minutes (within this 30 minutes the acetone was changed 2 times). The flies were then 
collected in a nylon mesh basket and allowed to air dry for 10-15 minutes. Once dry, flies 
were mounted on steel stubs and transferred into a high-vacuum sputtering device. The flies 
were coated for 2 minutes at 18mA giving them a 30nm gold coating. The Hitachi S-570 




2.9 Screen for Chromosomal Regions that Dominantly Interact with Atg16B 
pnrGAL4+UAS-Atg16B/TM6B,Tb[Gal80] virgin females were crossed to males 
bearing either a deficiency or duplication in trans to a dominantly marked balancer 
chromosome. Crosses were maintained at 25°C, the temperature at which pnrGAL4+UAS-
Atg16B/+ shows the intermediate thoracic cleft and reduced scutellum phenotype. A total of 
399 deficiency lines (Df) and 25 duplication (Dp) lines for the second and third chromosome 
were tested. pnrGAL4+UAS-Atg16B/Df or Dp and Df or Dp/+;pnrGAL4+UAS-Atg16B/+ 
progeny were compared to the pnrGAL4+UAS-Atg16B/Balancer or 
Balancer/+;pnrGAL4+Atg16B/+ sibs (these sibs were identified by dominantly marked 
balancers). The severity of the thoracic cleft and the reduced scutellum phenotype were 
evaluated and compared between the two groups. Any consistent difference (enhancement or 
suppression of the pnrGAL4+UAS-Atg16B phenotype were noted and interactors were further 
tested for confirmation. 
2.10 Screen for loci that dominantly interact with Atg16B 
Crosses similar to those described above were also used to identify individual loci that 
exhibit dominant interactions with Atg16B. Candidate genes, located within the interacting 
regions identified by the enhancer and suppressor screen, were identified. Various alleles, 
representing each candidate gene, were tested for modification of the thoracic cleft and 
reduced scutellum phenotype. Any consistent differences were noted. In addition, a number of 
stocks were tested that were not located within the interacting regions identified by the 
enhancer and suppressor screen but were associated with cell death.  
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2.11 Confirmation of Genetic Interactions BsgRNAi43307 and EP(3)3614 
 pnrGAL4+UAS-BsgRNAi43307/TM6B,Tb or pnrGAL4+EP(3)3614/TM3,Sb virgin 
females were crossed to males bearing an interacting deficiency in trans to a dominantly 
marked balancer chromosome. Crosses were performed in a similar manner to those 
mentioned above (Section 2.9). Many of the strong suppressors and strong enhancers were 
tested. pnrGAL4+UAS-BsgRNAi43307/Df or Df/+;pnrGAL4+UAS-BsgRNAi43307 /+ progeny 
were compared to pnrGAL4+UAS-BsgRNAi43307/Balancer or Balancer/+;pnrGAL4+UAS-
BsgRNAi43307/+ sibs (sibs were identified by dominantly marked balancers). The severity of 
the resulting black stripe down the midline of the thorax was evaluated and compared 
between the two groups. Any consistent differences in the black stripe phenotype between the 
two groups were considered possible interactors with pannier expression in the screen for 
chromosomal regions that dominantly interact with Atg16B. 
 Similarly, pnrGAL4+EP(3)3614/Df or Df/+; pnrGAL4+EP(3)3614/+ progeny were 
compared to  pnrGAL4+EP(3)3614/Balancer or Balancer/+; pnrGAL4+EP(3)3614/+ sibs. 
The severity of the resulting hairless stripe down the midline of the thorax and abdomen was 
evaluated and compared between the two groups. Any consistent differences in the hairless 
phenotype between the two groups were also considered possible interactors with pannier 
expression. Afterwards, any deficiency or duplication that resulted in an enhancement or 
suppression of both UAS-BsgRNAi43307 and EP(3)3614 were considered true interactors of 
pannier expression. 
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2.12 Wing Disc Dissection 
Wing disc dissections of wandering late third instar larvae were performed as in 
(Purves and Brachmann, 2007). Wing discs were mounted in 0.7% NaCl on a coverslip using 
the hanging drop method described in (Reed et al., 2009) and viewed using the Nikon Eclipse 
Confocal Microscope. All images were processed using Image J software 
(http://rsb.info.nih.gov/ij/). 
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Chapter 3. Development of Methodologies For Evaluating 























Note: Portions of this chapter have been published in the following journal article: Mohseni, 
N., McMillan, S.C., Chaudhary, R., Mok, J., Reed, B.H., 2009. Autophagy Promotes 
Caspase-Dependent Cell Death during Drosophila Development. Autophagy 5, 329-338.  
To view written permission from the editor of Autophagy please see Appendix E.
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Chapter 3. Development of Methodologies For Evaluating 
Autophagy and Caspase Activity In Various Tissues 
3.1 PCD in the AS: Using Lysotracker To Evaluate Autophagy 
 Lysotracker, a membrane permeable dye that labels acidic organelles, is a reliable 
indicator of increased autolysosomal and lysosomal activity. Although not specific for 
autophagy, lysotracker staining has been used as an indicator of autophagy in studies of 
starvation-induced autophagy and autophagic cell death (Rusten et al. 2004).  
The main advantage of using lysotracker is the ability to evaluate autophagy in living 
embryos, removing the need for fixation and embedding. In addition, lysotracker staining is a 
rapid method that allows the evaluation of autophagy and negates the time consuming process 
of introducing GAL4 and UAS constructs into mutant strains under investigation.  
In the following four subsections, we have used lysotracker as a vital stain for 
autophagy in the AS of wildtype and mutant backgrounds. 
3.1.1 Lysotracker: Visualizing Autophagy In The AS Of Control Embryos 
Lysotracker staining was initially performed on control embryos. Since future 
experiments were designed to use the GAL4-UAS system of inducible gene expression, the 
progeny of Yet1; LP1-GAL4 outcrossed to a stock carrying the recessive visible markers 
yellow (y = yellow body color) and white (w = white eyes) were chosen as our control 
embryos. Yet1 is a second chromosome vital enhancer trap that expresses GFP in the outer 
most cells (the perimeter cells) of the AS. Therefore, YET1 permits the easy identification of 
the AS in living embryos. LP1-GAL4 is a third chromosome GAL4 driver with a high 
specificity for the AS throughout embryonic development (Reed et al., 2004). 
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Confocal microscopy of lysotracker stained control embryos illustrates an increase in 
autophagy throughout dorsal closure in the AS (Figure 3.1). During early dorsal closure, the 
AS is largely lysotracker negative (lysotracker staining is weak, illustrating a few small 
punctate spots) (Figure 3.1A, C). Late dorsal closure stage embryos show the AS to be 
lysotracker positive (lysotracker staining is strong, illustrating many large punctate spots) 
(Figure 3.1D, F). Strong punctate lysotracker staining continues to be observed in the AS until 
it degenerates post dorsal closure (Figure 3.1G, I). It is interesting to note that macrophages, 
which are known to have large acidic compartments, stain prominently with lysotracker 
(Figure 3.1I). Furthermore, these results recapitulate observations made using LC3-GFP, and 
mCherry-DrAtg8a (fluorescent markers of autophagy). Expression of either fluorescent 
marker in the AS results in homogeneous localization during the early to mid dorsal closure 
stages of embryogenesis. However, expression from the late dorsal closure to the final stages 
of AS degeneration results in strong punctate localization of both fluorescent markers (data 
not shown; Reed Lab, Unpublished Data). These initial experiments served to demonstrate 
that lysotracker is a reliable indicator of autophagy in the AS. 
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Figure 3.1: Confocal micrographs of lysotracker stained control embryos expressing YET1 at 
three different stages of dorsal closure. (A-C) Yet1/+; LP1-GAL4/+ embryo in the early 
stages of dorsal closure, illustrating lysotracker staining that is faint (small red punctate 
spots). (D-F) Yet1/+; LP1-GAL4/+ embryo in the mid stages of dorsal closure, illustrating 
lysotracker staining that is strong with large red punctate spots. (G-I) Yet1/+; LP1-GAL4/+ 
embryo post dorsal closure illustrating strong lysotracker staining (large red punctate spots) in 
the degenerating AS. (I) Macrophages have been stained red with lysotracker (blue arrows) 
(A,D,G) Lysotracker images (B,E,H) YET1 expression (C,F,I) Merged images of Lysotracker 
and YET1 expression. (J) Diagram illustrating the location of the amnioserosa (pink). All 





















































































3.1.2 Lysotracker: Visualizing Autophagy In Apoptotic Defective Backgrounds 
To determine whether autophagy is independent of caspase activation, autophagy was 
evaluated in embryos expressing the caspase inhibitor p35 in the AS (Figure 3.2). Error was 
minimized in this experiment through the use of 3 controls. 1) UAS-p35; UAS-p35 (X;2) 
males were crossed to both yw and Yet1; LP1-GAL4 virgin females in the same collection. 
Pooling our crosses in this way ensured that all embryos were treated in parallel throughout 
the experiment. During imaging, the genotypes of embryos from this pooled cross were 
identified by the presence or absence of Yet1 expression in the perimeter cells. Yet1 
expression served to unambiguously identify embryos expressing the caspase inhibitor p35 in 
the AS, whereas embryos not expressing Yet1 represent an internal control.  2) All embryos 
collected from this pooled cross were stained in a single vial; therefore, all embryos were 
exposed to identical conditions throughout the lysotracker staining procedure. 3) All confocal 
laser settings were identical for each image captured. 
Confocal microscopy of embryos expressing p35 indicates there is no substantial 
difference between lysotracker staining of control and caspase-inhibited embryos (Figure 
3.2D, F). It is interesting to note that caspase-inhibited embryos display a persistent AS 
phenotype (Figure 3.2D, E, F). The elongated “tube-like” appearance of the AS in this 
background has been observed in other apoptotic deficient genetic backgrounds (Figure 
3.3A,C; Reed Lab Unpublished Data). Therefore, based on this phenotype, we are confident 
that this genetic background is associated with a high degree of caspase inhibition. This is 
further supported by the observation that macrophages are observed in the caspase-inhibited 
embryos by lysotracker staining but do not show any secondary acquisition of GFP that is 
normally associated with AS degeneration (Figure 3.2F). It is concluded that ectopic p35 
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expression and consequently the suppression of caspase activity did not alter lysotracker 
staining in the AS. Our interpretation of this result is that the induction of autophagy does not 
require caspase activity in the AS.  
 To further demonstrate that the induction of autophagy does not require caspase-
activation, we sought to establish that autophagy continues unabated in mutants defective in 
the activation of apoptosis. Homozygous deficiencies of the pro-apoptotic gene cluster that 
includes hid, grim, and rpr (abbreviated as HGR) are well known to be completely deficient 
in apoptosis (White et al., 1994) and display a persistent AS phenotype (Mohseni et al., 
2009). Therefore, the HGR deficient background was examined using lysotracker staining. In 
order to unambiguously identify embryos that lack both copies of the HGR genes we used two 
recombinant stocks, each carrying a single chromosomal deletion of the HGR genes. The first 
stock carried the Df(3L)ED225 deletion and the LP1-GAL4 driver and the second stock 
carried the Df(3L)H99 deletion and a UAS-mCD8-GFP reporter. When using this elegant 
design, only embryonic progeny homozygous for deletions of the HGR genes express GFP.  
Confocal micrographs of embryos from this cross demonstrate that HGR deficient 
embryos display unaltered levels of lysotracker staining, indicative of the normal progression 
of autophagy in this background (Figure 3.3A, C). Also, these embryos present a persistent 
AS phenotype, indicating that the embryos were defective for the activation of apoptosis 
(Figure 3.3A, B, C). In summation, the results of lysotracker staining in apoptotic defective 
backgrounds clearly demonstrate that the induction of autophagy does not require caspase 
activation or apoptosis. 
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Figure 3.2: Lysotracker staining of mid dorsal closure stage control embryos and late stage 
caspase-inhibited embryos. (A-C) Montage of a lysotracker stained UAS-p35/+; UAS-p35/+ 
embryo, in the mid stage of dorsal closure. The total depth of the montage is 4.54µm, which 
has been divided into 3 slices. Depth increases from A to C. Image depicts strong punctate 
lysotracker staining throughout the AS (D) Single image of UAS-p35/+; UAS-p35/Yet1; LP1-
GAL4/+ embryo illustrating strong punctate lysotracker staining in a persistent AS. (E) Image 
of UAS-p35/+; UAS-p35/Yet1; LP1-GAL4/+ embryo. YET1 expression (green) can be seen 
clearly in the perimeter cells of the AS, identifying embryos that are expressing p35. (F) 
Merged lysotracker and YET1 image of UAS-p35/+; UAS-p35/Yet1; LP1-GAL4/+ embryo, 
illustrating punctate lysotracker staining in the persistent AS. Macrophages also observed 
(blue arrow) with no GFP acquisition in caspase-inhibited embryos. All crosses were 
















































Figure 3.3: Lysotracker staining of HRG deficient embryo. (A-C) Lysotracker staining of an 
embryo with the genotype: yw; LP1-GAL4, Df(3L)ED225/UAS-mCD8-GFP+Df(3L)H99. (D, 
E, F) Control embryo that has been stained by lysotracker. (A, D) Lysotracker staining is 
punctate in HRG deficient (A) and control (D) embryos, illustrating autophagy proceeds 
unabated in HRG deficient embryos. (B, E) Illustrates the presence and absence of mCD8-
GFP expression in HRG deficient (B) and control (E) embryos respectfully. (C) Image 
illustrating both lysotracker staining and mCD8-GFP expression in an embryo that is HRG 
deficient. (F) Merged image illustrating lack of GFP and punctate lysotracker staining in the 
control embryo. All crosses were performed at 25°C and confocal settings were identical for 
















































3.1.3 Lysotracker: Atg1 Overexpression Results In Increased Autophagy In The AS 
The ectopic overexpression of Atg1, a key regulator of autophagy, is known to turn on 
or elevate autophagy during non-starvation conditions (Scott et al., 2007). Therefore, we 
wished to evaluate the effect of Atg1 overexpression in the AS. Lysotracker staining was 
performed on embryos overexpressing Atg1 in the AS using UAS-Atg16A under the control of 
the LP1-GAL4 driver (Figure 3.4B). 
Confocal micrographs of Atg16A over-expressing embryos demonstrate that 
lysotracker staining in the AS of early DC stage embryos is greatly increased relative to the 
control (Figure 3.4). Similar results, using UAS-mCherry-DrAtg8a (mCherry), have been 
achieved, reinforcing this data (Reed Lab, Unpublished Data) (For details on mCherry See 
Section 3.3). 
Interestingly, previous work has shown that high levels of Atg1 kinase expression 
results in early AS cell death. Such embryos fail in DC, and this defect is completely rescued 
through the ectopic expression of p35, a caspase inhibitor (Mohseni et al., 2009). Together, 
these results suggest that high levels of autophagy induce caspase activation. 
3.1.4 Lysotracker: Constitutive Activation of ∆αInR Decreases Autophagy In The AS. 
In contrast to the previous section, involving Atg16A overexpression, lysotracker 
staining was performed on embryos in which autophagy had been disrupted in the AS. 
Autophagy was inhibited in the AS through the expression of UAS-∆αInR, an activated 
insulin receptor. Error was minimized in this experiment through the use of the same three 3 
controls mentioned previously (See section 3.1.2). The downregulation of autophagy in these 
embryos resulted in a substantial decrease in lysotracker staining (Figure 3.5 A, C) relative to 
the control (Figure 3.5 D, F). Similar results, demonstrating a decrease in autophagy in the AS 
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of ∆αInR expressing embryos, have been observed using LC3-GFP and transmission electron 
microscopy (TEM)  (Mohseni et al., 2009; Reed Lab Unpublished Data). Also, it has been 
shown that the expression of UAS-∆αInR results in a persistent AS phenotype (Mohseni et al., 
2009). Together, these results suggest that an increase in autophagy is required for the 
elimination of the AS. 
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Figure 3.4: Confocal micrographs of early dorsal closure stage embryos that have been 
stained by lysotracker. (A) Control, yw, embryo illustrating weak lysotracker staining with 
very few small punctae. (B) UAS-Atg16A/LP1-GAL4 embryo, overexpressing Atg1 in the AS. 
Image illustrates very strong lysotracker punctae in the AS. Crosses were performed at 29ºC. 



















Figure 3.5: Confocal micrographs of mid to late dorsal closure stage embryos that have been 
stained by lysotracker. (A-C) Control embryo with the genotype UAS-∆αInR/+. Image 
illustrates strong lysotracker staining with large punctae in the AS.  (D-F) Autophagy 
inhibited, Yet1/+;UAS-∆αInR/LP1-GAL4, embryo, illustrating weak lysotracker staining with 
very few small punctate spots in the AS. (A, D) Lysotracker images. (B) Image of YET1 
expression in the perimeter cells of the AS. The presence of YET1 expression confirms the 
constitutive expression of ∆αInR. (E) The absence of YET1 expression in the perimeter cells 
of the AS confirms the absence ∆αInR expression in the embryo. (C) Merged image 
illustrating lysotracker staining (red) and YET1 expression (green). (F) Merged image that 
illustrates only lysotracker staining, confirming ∆αInR is not being expressed in the AS. All 















































3.2 Apoliner: Evaluating Caspase-Activity in Live Tissues Throughout 
Development 
 UAS-Apoliner, a caspase sensor, was employed to evaluate caspase activity in the AS, 
dorsal larval epidermis, and imaginal wing discs. Apoliner allows the detection of caspases in 
live tissues through the use of two fluorophores, RFP and GFP (Bardet et al., 2008). 
Normally, when caspases are inactive, a caspase-sensitive site links the two fluorophores of 
Apoliner. However, upon activation of caspases the caspase-sensitive site between the two 
fluorophores is cleaved. Since each fluorophore is connected to a different subcellular 
localization signal, GFP to a nuclear targeting signal and RFP to a transmembrane domain, 
the cleavage of the caspase sensitive site allows GFP to accumulate in the nucleus, while the 
RFP persists at the membrane (Bardet et al., 2008). Therefore, using this method, the 
activation of caspases in cells can be detected by the accumulation of GFP in the nucleus. 
3.2.1 Apoliner: Evaluating Caspase Activity In The AS During Embryogenesis 
Timelapse confocal microscopy of embryos expressing UAS-Apoliner was performed 
to assess the effectiveness of Apoliner as a caspase sensor during AS degeneration. 
Embryonic progeny carrying UAS-Apoliner and the AS-specific driver LP1-GAL4 were 
imaged throughout dorsal closure. As a result, it was demonstrated that, prior to their 
elimination, GFP accumulates in the nucleus of AS cells expressing UAS-Apoliner (Figure 
3.6). During the early DC stages of embryogenesis no caspase activity is detected in the AS 
with the exception of a few cells that were in the process of being extruded from the 
epithelium (Figure 3.6 A, B). Interestingly, the accumulation of nuclear GFP in AS cells prior 
to extrusion indicates that caspases are activated in cells before they are eliminated from the 
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epithelium (data not shown). During the mid-dorsal closure stage, a number of nuclear GFP 
positive AS cells are observed at the anterior and posterior ends of the AS, illustrating the 
induction of caspase activity (Figure 3.6C). By the late stages of dorsal closure, nuclear GFP 
is observed throughout the AS (Figure 3.6D). This accumulation of nuclear GFP continues in 
the AS well into the post-dorsal closure stages when the entire AS degenerates (Figure 3.6E, 
F). Together, these results indicate that Apoliner is a reliable indicator of caspase activation in 
the AS. 
It has also been shown using Apoliner that the downregulation of autophagy, through 
the expression of UAS-∆αInR, strongly reduces nuclear GFP localization (Reed Lab 
Unpublished Data). Therefore, an increase in autophagy is required for caspase activation in 
the AS. In summation, these results suggest that the relationship between autophagy and 
caspase activation is epistatic, whereby autophagy acts to induce caspase activation during the 




Figure 3.6: Diagram illustrating the induction of caspase activity in the AS of an embryo with 
the genotype +/+; UAS-Apoliner/+; LP1-GAL4/+, throughout embryogenesis. (A) Early DC 
stage embryo illustrating no nuclear GFP. Both RFP and GFP co-localize at the membrane. 
(B) Early DC stage embryo illustrating an AS cell with nuclear GFP that is in the process of 
being extruded from the epithelium (red arrow). (C) Mid DC stage embryo illustrating a large 
number of AS cells with nuclear GFP at the posterior and anterior regions of the AS. (D) Late 
DC stage embryo illustrating nuclear GFP throughout the AS. (E) Post DC stage embryo 
illustrating cells with nuclear GFP throughout the AS. (F) Post DC stage embryo illustrating a 
degenerating AS. Nuclei at this stage are unobservable. In all images: GFP (yellow) RFP 
















































3.2.2 Apoliner: Evaluating Caspase Activity In The Dorsal Third Instar Larval 
Epidermis 
 As outlined in the previous sections, it has been shown that high levels of autophagy 
in the AS result in caspase activation. Also, it has been shown that Apoliner is a reliable 
method to assess caspase activation. Expanding upon these findings, Apoliner was used to 
examine autophagy-induced cell death in the larval epidermis. 
To visualize dorsal larval epithelial segments, a new recombinant stock, 
pnrGAL4+UAS-Apoliner/TM6,Tb was constructed on the third chromosome (For crossing 
Scheme See Appendix B – Figure B.3). This stock contains pnrGAL4, a GAL4 driver that 
enables ectopic gene expression in a medial-dorsal stripe throughout development, and UAS-
Apoliner (See Section 3.2). This recombinant stock allows the assessment of caspase activity 
by outcrossing pnrGAL4 + UAS-Apoliner to any other available UAS-construct. In the 
progeny, the dorsal larval epidermis is readily examined by stereomicroscopy for the absence 
or presence of nuclear localized GFP (RFP was not examined in the larval epidermis due to 
the absence of a red filter on the stereomicroscope)(Figure 3.7). 
To test the recombinant stock, preliminary live imaging was performed on control 
larvae that express UAS-Apoliner under the control of pnrGAL4. Throughout the live imaging 
sessions, larval epithelial cells of the 1st to 4th abdominal segments were clearly visible as 
distinct bands of non-nuclear localized GFP on the dorsal surface of the third larval instar 
(Figure 3.7A). 
To evaluate the effect of Atg16B overexpression in the larval epidermis the same 
recombinant stock, pnrGAL4+UAS-Apoliner/TM6,Tb, was crossed to UAS-Atg16B. 
Stereomicroscopic live imaging of third instar larval progeny overexpressing Atg16B 
illustrates a severe decrease in the number of cells expressing UAS-Apoliner (Figure 3.7C). 
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Also, the remaining larval epidermal cells contained nuclear localized GFP, suggesting that 
the Atg16B overexpressing cells are being eliminated through caspase-activation. 
To determine whether the disappearance of the larval epidermal cells overexpressing 
Atg16B was a consequence of caspase activation, UAS-p35; UAS-p35 virgin females were 
crossed to the newly constructed pnrGAL4+UAS-Atg16B+UAS-Apoliner/TM6,Tb[GAL80] 
stock (Crossing Scheme Available in Appendix B – Figure B.3). Non-nuclear localization of 
GFP, in small patches of larval epidermal cells, was observed in third instar progeny co-
expressing p35, Atg16B, and Apoliner (Figure 3.7 G). Therefore, the co-expression of p35 
partially rescued the elimination of larval epidermal cells overexpressing Atg16B. 
To ensure that the ectopic expression of p35 in the larval epidermis resulted in a 
control phenotype, UAS-p35; UAS-p35 virgin females were crossed to pnrGAL4+UAS-
Apoliner/TM3,Sb males. As a result, non-nuclear GFP localization in the larval epidermis was 
observed in third instar progeny ectopically expressing p35 (Figure 3.7 E). Therefore, ectopic 
p35 expression does not alter the subcellular localization of GFP in larval epidermal cells. 
In order to better visualize the larval epidermis, similar experiments were performed 
using a nuclear GFP reporter instead of Apoliner (Figure 3.7,B, D, F) (For details on the 
construction of the pnrGal4+UAS-GFPnls/TM3,Sb Stock See Appendix B – Figure B.1). 
Comparable to previous results, the overexpression of Atg16B results in a severe decrease in 
cells expressing nuclear GFP (Figure 3.7D). Also, the ectopic expression of p35 resulted in a 
phenotype identical to the control (Figure 3.7B), as nuclear GFP was expressed in distinct 
bands along the dorsal surface of the larval epidermis (Figure 3.7F). 
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Figure 3.7: Stereomicroscopic images of the 1st to 4th abdominal segments of the third instar 
dorsal epidermis using UAS-Apoliner and UAS-GFPnls. (A) Control, pnrGAL4+UAS-
Apoliner/+, larvae expressing non-nuclear GFP in the larval epidermis. (B) Control, 
pnrGAL4+UAS-GFPnls/+, larvae expressing nuclear GFP in the larval epidermis. (C) 
pnrGAL4+UAS-Atg16B+UAS-Apoliner/+ larvae overexpressing Atg16B in the dorsal larval 
epidermal cells. Image illustrates two small patches of cells with nuclear GFP expression 
(blue arrows). (D) pnrGAL4+UAS-GFPnls/UAS-Atg16B larvae overexpressing Atg16B in the 
larval epidermal cells. Image illustrates an absence of cells containing nuclear GFP in the 
dorsal abdominal segments. (E) Control, UAS-p35/+; UAS-p35/+; pnrGAL4+UAS-
Apoliner/+, larvae expressing non-nuclear GFP in the larval epidermis. (F) Control, UAS-
p35/+; UAS-p35/+; pnrGAL4+UAS-GFPnls/+, larvae expressing nuclear GFP in the larval 
epidermis. (G) UAS-p35/+; UAS-p35/+; pnrGAL4+ UAS-Atg16B + UAS-Apoliner/+ larvae 






































































3.2.3 Apoliner: Evaluating Caspase Activity In The Third Instar Imaginal Wing Disc 
In a recent study, Scott et al., have demonstrated that the overexpression of Atg1 in 
patches of the imaginal wing disc results in the induction of autophagy-dependent caspase 
activation (2007). Therefore, we sought to confirm and evaluate the activation of caspases by 
autophagy in the proximal area of the third instar imaginal wing disc.  
First, confocal microscopy of control embryos expressing UAS-Apoliner was 
performed to evaluate Apoliner expression with respect to its utility in visualizing the 
proximal area of the wing disc. As a result, GFP and RFP were co-localized and clearly 
visible at the membrane of the imaginal disc cells (Figure 3.8A, B, C). Therefore, it was 
determined that Apoliner is a useful tool to observe caspase activation in the wing disc. 
To determine whether the overexpression of Atg16B in the wing disc induces caspase 
activation, the UAS-Apoliner+UAS-Atg16B+pnrGAL4/TM6,Tb[Gal80] stock was outcrossed 
to a yw stock. As a result, nuclear localized GFP and membrane tethered RFP were clearly 
observed in cells overexpressing Atg16B, demonstrating that high levels of autophagy in the 
wing disc results in caspase activation (Figure 3.8 D, E, F).  
Next, to establish whether the overexpression of Atg16B in the wing disc resulted in 
autophagy-dependent caspase activation, UAS-p35; UAS-p35 virgin females were crossed to 
UAS-Apoliner+UAS-Atg16B+pnrGAL4/TM6,Tb[Gal80] males. As a result, non-nuclear 
localized GFP was observed in the wing discs of progeny co-expressing p35, Atg16B, and 
Apoliner (Figure 3.8 J, K, L). 
To ensure that p35 expression in the wing disc does not result in an observable 
phenotype, UAS-p35; UAS-p35 virgin females were crossed to pnrGAL4+Apoliner/TM6, Tb 
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males. As a result, wing discs appeared similar to the controls as non-nuclear localized GFP 
was observed in progeny co-expressing Apoliner and p35 (Figure 3.8 G, H, I). 
 Together, these observations indicate that the induction of autophagy, via the 
overexpression of Atg16B, results in autophagy-dependent caspase activation in the wing disc 
of third instar larvae. 
3.3 mCherry: Evaluating Autophagy in Wing Discs Overexpressing Atg16B 
To ensure that autophagy levels are increased in wing discs overexpressing Atg16B, 
autophagosomes and autolysosomes were detected using UAS-mCherry-DrAtg8a. mCherry is 
an acid-insensitive fluorescent protein that is fused to DrAtg8, an autophagy related protein 
that is essential for the formation of autophagosomes (Nezis et al., 2009). 
In the controls, the expression of mCherry-DrAtg8a, in the proximal area of the wing 
disc, results in homogeneous RFP localization in the cytoplasm, illustrating low levels of 
autophagosome and autolysosome formation. This result confirms the occurrence of low 
levels of autophagy in the wing discs of third instar larvae (Figure 3.9A, C). 
However, larvae expressing UAS-Atg16B and UAS-mCherry-DrAtg8a, in the proximal 
area of the wing disc, had strong punctate RFP localization in the cytoplasm, illustrating a 
strong increase in autophagosome and autolysosome formation (Figure 3.9D, F). This result 
indicates that the level of autophagosome and autolysosome formation is increased in the 
wing disc when Atg16B is overexpressed. It is assumed from this data that autophagy levels 
are increased in wing discs overexpressing Atg16B, however, further research should be 
performed to verify that the flux through the autophagy pathway has increased as well as the 
number of autophagosomes and autolysosomes. 
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Figure 3.8: Confocal Micrographs of wing discs dissected from third instar larvae. (A-C) 
Control wing disc with the genotype: pnrGAL4+UAS-Apoliner/+. Images illustrate a wing 
disc in which GFP and RFP are co-localized (white) at the cell membrane. (D-F) Wing disc 
with the genotype: pnrGAL4+UAS-Apoliner+UAS-Atg16B/+. These images illustrate the 
nuclear localization of GFP (red arrows) due to caspase activity. (G-I) Control wing disc with 
the genotype UAS-p35/+; UAS-p35/+; pnrGAL4+UAS-Apoliner/+. These images illustrate 
the co-localization of GFP and RFP at the cell membrane due to an absence of caspase 
activity.  (J-L) UAS-p35/+; UAS-p35/+; pnrGAL4 + UAS-Apoliner + UAS-Atg16B/+: wing 
disc, illustrating a rescue phenotype. GFP and RFP are co-localized and reside at the 
































































































Figure 3.9: Confocal Micrographs of third instar wing discs expressing UAS-mCherry-
DrAtg8a. (A-C) Control wing disc with the genotype: pnrGAL4/UAS-mCherry-DrAtg8a. (A) 
Image illustrating homogeneous RFP (red) localization in the control wing disc. (B) 
Transmitted light image of the proximal area of the control wing disc. (C) mCherry and 
transmitted light images merged together. (D-F) Wing disc with the genotype: 
pnrGAL4+Atg16B/UAS-mCherry-DrAtg8a. (D) Image illustrating strong punctate RFP due to 
Atg16B overexpression. (E) Transmitted light image of the proximal area of a wing disc 
overexpressing Atg16B. (F) mCherry and transmitted light images of the wing disc 
















































3.4 Results: Studying Autophagy-Dependent Caspase Activation in Adult 
Cuticular Structures 
In the previous sections it was determined that the overexpression of Atg16B in the 
larval wing disc results in a dramatic increase in autophagosome and autolysosome formation 
and is associated with caspase-activation. Similarly, the overexpression of Atg16B results in 
the inappropriate elimination of the larval epidermal cells. Together, the elimination of these 
tissues promotes an interesting adult cuticular phenotype. This phenotype was examined in 
detail using Scanning Electron Microscopy (SEM). 
When compared to yw, pnrGAL4 adults exhibit normal thorax and abdomen 
development, demonstrating a wildtype phenotype (Figure 3.10). Therefore, pnrGAL4 was 
used as the control for all subsequent SEM images (Figure 3.11 A, B).  
After establishing pnrGAL4 as a control, SEM was performed on adult Drosophila 
overexpressing Atg16B along the dorsal midline throughout development. Scanning electron 
micrographs of adults overexpressing Atg16B illustrate strong thoracic and moderate 
abdominal clefts and a reduced scutellum (Figure 3.11 E, F). To establish whether this adult 
cuticular phenotype was the result of autophagy-induced caspase activation, p35 was co-
expressed in tissues overexpressing Atg16B throughout development. As a result, the co-
expression of p35 is pupal lethal and does not suppress the thoracic, abdominal or scutellar 
phenotype associated with Atg16B overexpression (data not shown). Additionally, adults 
ectopically expressing p35 alone demonstrate a slight cleft down the dorsal midline of the 
notum and mild abdominal cleft (Figure 3.11 C, D).  
Interestingly, since we are using an expression system that can be modulated by a shift 
in temperature, we know that these adult cuticular phenotypes can be enhanced or suppressed 
based on the levels of Atg16B expression.  Adults raised at 29ºC, increasing Atg16B expression 
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in tissues specified by pnrGAL4, completely lack a scutellum and display a more prominent 
thoracic and abdominal cleft (Figure 3.11 G, H). In contrast, adults that were allowed to 
develop at 18ºC, decreasing Atg16B expression, have a less prominent thoracic and abdominal 







Figure 3.10: Scanning Electron Micrograph of Drosophila adult cuticular structures. (A,B) 
Images illustrating the thorax and scutellum, collectively called the notum. (C, D) Images 
illustrating the dorsal surface of the abdomen. (A,C) Adult cuticular structures of a fly with 
the genotype: yw. (B, D) Adult cuticular structures of a fly with the genotype: pnrGAL4/+. 































Figure 3.11: Scanning Electron Micrographs of adult cuticular structures. (A, B) pnrGAL4/+ 
adult notum (A) (scutellum identified by the red arrow) and abdomen (B) demonstrating a 
wildtype phenotype. (C, D) UAS-p35/+; pnrGAL4/+ adult developed at 25ºC exhibiting a 
hairless line with a slight indent down the midline of the thorax (C) and a mild abdominal 
cleft (blue arrow)(D). (E, F) pnrGAL4/UAS-Atg16B adult that developed at 25ºC exhibiting a 
reduced scutellum (green arrow) and a thoracic cleft (orange arrow) (E). A moderate cleft 
down the abdomen is also observed (F). (I, J) pnrGAL4/UAS-Atg16B adult that developed at 
29ºC illustrating a severe cleft down the dorsal midline of the thorax (I) and a strong cleft 


























































3.5 Results: Evaluating Autophagy Dependent Caspase-Activity during 
Metamorphosis. 
In the previous section it was observed that the overexpression of Atg16B, in tissues 
specified by pnrGAL4, results in a striking adult cuticular phenotype (Figure 3.11E, F).  
Unfortunately, this adult cuticular phenotype could not be rescued through co-expression of 
p35. Also, the ectopic expression of p35 alone results a mild abdominal cleft along with a 
slight cleft along the midline of the notum (Figure 3.11 C, D). 
Since these results were unexpected, the larval epidermis and presumptive adults cells 
were observed in detail throughout metamorphosis. In particular, the effect of ectopic p35 
expression was observed in tissues overexpressing Atg16B. To visualize these dorsal epithelial 
segments, pnrGAL4+UAS-GFPnls/TM3,Sb and pnrGAL4+UAS-Atg16B+UAS-Apoliner/TM6, 
Tb[GAL80] were crossed to the various UAS-constructs. When using this elegant design, 
only the GFP expressing progeny, resulting from these two parental stocks, are those 
expressing the UAS-constructs. 
3.5.1 Autophagy-Activated Apoptosis During Pharate Adult Formation 
Timelapse stereomicroscopic live imaging of control pupae expressing nuclear GFP 
under the control of the pnrGAL4 driver reveals the dynamic behavior of tissues during 
metamorphosis. Through this form of live imaging it is demonstrated that the large polyploid 
larval epidermal cells undergo PCD and dissociate as the abdominal histoblast nests expand 
and fuse with neighboring nests (For more information on abdomen development, See 
Appendix A Section A.4). Interestingly, the formation of the adult abdomen occurs much 
later than the fusion of the wing imaginal discs to form the notum. Thoracic larval epidermal 
PCD and the fusion of the imaginal wing discs could not be properly evaluated as thorax 
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development occurs too quickly. However, the formation of the scutellum, from a protrusion 
at the dorsal-posterior end of the fused wing disc, can be observed clearly using this method 
(Figure 3.12 – Control) (For more information on thorax development, See Appendix A - 
Section A.3). 
Afterwards, stereomicroscopic live imaging was performed on pupae ectopically 
expressing p35. The ectopic expression of p35, in tissues specified by pnrGAL4, results in a 
persistent larval epidermis. The continued presence of the abdominal larval epithelial cells 
inhibits the proper fusion of the histoblast nests, resulting in an abdominal cleft down the 
dorsal midline. Also, a slight thoracic cleft is observed in the later stages of development 
(Figure 3.12 – p35). The development of the scutellum appears to be unaffected by the 
ectopic expression of p35. 
In contrast to previous results involving p35 expression, the ectopic overexpression of 
Atg16B results in the premature elimination of larval epithelial cells (As observed previously 
in Figure 3.7 C, D). Furthermore, upon entering the domain of pnrGAL4, histoblast nests 
acquire ectopic overexpression of Atg16B and subsequently undergo cell death. This premature 
larval epithelial and inappropriate histoblast cell death appears to inhibit the proper fusion of 
histoblast nests, resulting in a strong abdominal cleft down the dorsal midline (Figure 3.12 - 
Atg16B). During the later stages of development, a thoracic defect could also be observed in 
pupae overexpressing Atg16B (Figure 3.12 - Atg16B). Although wing disc fusion could not be 
directly assessed, it is presumably the elimination of the larval epidermal cells and imaginal 
wing disc cells that inhibits thorax closure, resulting in an adult cuticular phenotype. This 
assumption was reinforced by previous work, revealing that the pre-pupal to the mid 
phanerocephalic stages, a developmental period in which wing discs grow, divide and fuse 
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with their counterparts (Fristrom and Fristrom, 1993), were the most sensitive developmental 
stages, with respect to Atg16B overexpression (See Appendix C). 
Finally, as expected the co-expression of p35 does not rescue the adult cuticular 
phenotype associated with the overexpression of Atg16B (Figure 3.12 – p35; Atg1). Upon 
initial observation, the larval epidermis is absent, indicating p35 could not rescue the 
premature cell death of the larval epidermis during the pupal stages. Furthermore, upon 
entering the domain of pnrGAL4, histoblast nests are eventually eliminated after acquiring 
p35 and Atg16B expression. The elimination of histoblast nests inhibits abdomen formation, 
resulting in a strong abdominal cleft. During the later stages of development, a strong defect 
in the notum (a strong cleft and absent scutellum) was observed in pupae co-expressing 
Atg16B and p35 (Figure 3.12 – p35; Atg1). Eventually, the co-expression of Atg16B and p35 
results in lethality during the late pupal stages. 
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Figure 3.12: Timelapse stereomicroscopic live imaging of four Drosophila pupae. Each 
subsequent image is 7.5 hrs with the earliest developmental stage at the top and the latest 
developmental stage at the bottom. The captions along the bottom of the diagram indicate the 
control or the genotype of the four pupae. (Control) Pupae with the genotype: 
pnrGAL4+UAS-GFPnls/+, expressing nuclear GFP in the abdominal larval epidermis 
(between red stars) and notum. The abdominal larval epidermal cells undergo PCD while the 
histoblast nests expand and fuse with their counterparts. (p35) Pupae with the genotype: UAS-
p35/+; pnrGAL4+UAS-GFPnls/+, ectopically expressing p35 in the domain of pnrGAL4. 
Persistent larval epidermal cells inhibit the fusion of the histoblast nests (red arrow), resulting 
in an abdominal cleft. (Atg16B): Pupae with the genotype: pnrGAL4+UAS-GFPnls/UAS-
Atg16B, overexpressing Atg16B in the domain of pnrGAL4. Larval epidermal cells are absent 
(top blue arrow). AS abdominal histoblasts acquire Atg16B overexpression as they enter the 
domain of pnrGal4 and subsequently die, resulting in a large abdominal cleft (bottom blue 
arrow). Near the end of development a thoracic cleft is present (orange arrow). (p35;Atg16B) 
Pupae with the genotype: UAS-p35/+;UAS-p35/+;UAS-Atg16B+pnrGAL4+UAS-Apoliner/+, 
ectopically expressing p35 in cells overexpressing Atg16B. There is no rescue of the larval 
epidermis, resulting in an abdominal and thoracic cleft (green arrows). All crosses were 
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Chapter 4. Genetic Screen  
In previous chapters, it was established that autophagy induces caspase-activity in the 
third instar wing disc and presumably the larval epidermis. Unfortunately, the striking adult 
cuticular phenotype associated with the overexpression of Atg16B could not be rescued 
through the co-expression of p35. The inability to rescue the adult cuticular phenotype 
indicates there is no direct correlation between the adult phenotype and autophagy-dependent 
caspase activation. However, through changes in temperature, it was demonstrated that the 
adult cuticular phenotype could be enhanced or suppressed based on the levels of Atg16B 
expression. Two possibilities might explain these observations. First, high levels of autophagy 
could result in the caspase-independent autophagic death of tissues during the late stages of 
metamorphosis. Second, it could be that the adult cuticular phenotype is independent of cell 
death and results from a failure of autophagic cells to secrete adult cuticle. 
In either case, the adult cuticular phenotype is an attractive background to screen for 
dose-sensitive modifiers of Atg16B overexpression. Any chromosomal regions identified as 
harboring a dose-sensitive modifier might be associated with either the progression of 
autophagy or a disruption of the expression of the pnrGAL4 driver. While the disruption of 
pnrGAL4 might be considered a false positive in the genetic screen, the regulation of the 
pannier gene is itself of interest in terms of pattern formation during Drosophila 
development. Clearly, however, it is the goal of this study to identify genes that regulate 
autophagy and, in particular, promote caspase activation in response to the up-regulation of 
autophagy. 
A dose-sensitive modifier screen of the adult cuticular phenotype will certainly “cast a 
broad net” and will potentially identify regions of the genome that house genes involved in 
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any aspect of the regulation of autophagy. Also, any regions that affect the regulation of the 
pnrGAL4 driver, and the secretion of the adult cuticle could be identified. Therefore, a 
secondary screen will be required to separate these different categories of interactors (See 
Future Directions). 
4.1 Genetic Screen for Chromosomal Regions that Dominantly Interact 
with Atg16B 
A genetic screen, using Atg16B overexpression at 25°C in the domain of pnrGAL4 
expression as our sensitized genetic background, was performed to find dose-sensitive 
modifiers of the Atg16B overexpression phenotype. 399 deficiencies were tested,1 198 on the 
2nd chromosome and 201 on the 3rd chromosome that collectively remove an estimated 92% 
of the 2nd and 3rd chromosomes (Table 4.2). In addition, 25 duplications, that cover an 
estimated 66% of the 2nd and 3rd chromosomes, were tested (See Appendix D for a complete 
list of duplications and deficiencies). During the genetic screen, progeny carrying one copy of 
the deficiency (or duplication) and overexpressing Atg16B were compared to sibling Atg16B 
overexpressing progeny carrying a balancer chromosome (For details see Materials and 
Methods). The severity of the thoracic and abdominal clefts and the reduced scutellum 
phenotype was evaluated and compared between the two groups. Dominant interacting 
deficiencies and duplications were identified based on the criteria given on Table 4.1. It 
should be noted that the “Undefined Modifier” phenotypes are so named because they exhibit 
characteristics of both enhancers and suppressors. These “Undefined Modifiers” have no 
thoracic cleft, indicating a suppressed phenotype; however, the notum is small with no 
scutellum and the abdomen possesses a strong to moderate cleft, indicating an enhanced 
                                                        
1 Deficiency = Single Chromosomal Deletion 
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phenotype. In addition, some interacting deficiencies were identified as false positives. False 
positives are classified as any modifier that effects pannier expression, deletes the pannier 
region, deletes a region that contains a haplo-insufficient lethal loci, or a deletes a Minute 
region.2 However, an interacting deficiency covering a Minute region is not classified as a 
false positive if another non-interacting deficiency covers the same area as the Minute. 
Deficiencies and duplications suspected to be false positives are indicated in Appendix D. 
Based on the previously mentioned criteria (Table 4.1), seventy-nine out of the 399 
deficiencies were identified that modify the Atg16B overexpression phenotype. Of the seventy-
nine deficiencies, forty-two are dominant enhancers, twenty-four are dominant undefined 
modifiers, and thirteen deficiencies are dominant suppressors (Figures 4.2-4.5, Tables 4.2-
4.7). These interacting deficiencies account for 19.80% of all tested deficiencies (Table 4.2). 
Of the seven interacting duplications, two are dominant suppressors, four are dominant 
enhancers, and one is an undefined modifier (Figures 4.2- 4.5; Tables 4.3-4.7). These 
interacting deficiencies and duplications represent a collective 44 “interacting regions” on the 
second and third chromosomes (Tables 4.3-4.7; Figures 4.2- 4.5). Interacting regions, in this 
thesis, are defined as cytological locations on the chromosome that contain overlapping 
interacting deficiencies and/or duplications. These interacting regions do not contain non-
interacting deficiencies (Figure 4.1A).  If an interacting deficiency does not overlap with 
another interacting deficiency the interacting region is identical to the cytology of that 
deficiency (Figure 4.1B).  
 
                                                        
2 Minute regions contain loci that code for ribosomal proteins. The deletion of a Minute region results 
in a developmental delay and short, usually thin, bristles (Ashburner, 1989). 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Table 4.1: Criteria For The Classification Of Phenotypes During The Genetic Screen  
Class Associated Phenotypes3 
Undefined 
Modifier (UM) 
A “Coherent thorax phenotype”. 
- No thoracic cleft but thorax is small. 
- No scutellum 
- Strong to moderate abdominal clefts 
Enhancer (EN+) 
A Moderate Enhancer – Semi Lethal Phenotype 
- 5+ escapers 
- Strong thoracic clefts 
- Strong abdominal clefts.  
- No scutellum. 
Enhancer (EN++) 
A Strong Enhancer – Lethal Phenotype 
- 1 - 4 escapers  
- Strong thoracic clefts 
- Strong abdominal clefts 
- No scutellum 
Suppressor (SU-) 
A Moderate Suppression Phenotype 
- Viable 
- Mild thoracic cleft - An indent along the midline of the 
thorax. Overall size similar to wildtype. 
- Moderate to mild abdominal clefts. 
- Mild reduction in scutellar size (no less than ½ the size of 
wildtype).  
Suppressor (SU--) 
A Strong Suppression Phenotype  
- Viable 
- No thoracic cleft - A hairless line and a very slight indent 
along the thoracic midline. Overall size close to that of 
wildtype.  
- Mild to no abdominal cleft  




3 All identified enhancements, suppressions and undefined modifiers were classified based on these 
criteria. 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Figure 4.1: Diagram illustrating the definition of an “interacting region” and the criteria for 
identifying targeted interacting regions (A) Diagram illustrating the interacting region 
associated with three overlapping deficiencies (orange and yellow rectangles) and a 
complementing interacting single duplication (blue rectangle). (B) Diagram illustrating the 
interacting region associated with a single, non-overlapping deficiency (yellow rectangle) 
with a complementing single duplication (blue rectangle). The interacting regions are located 
between the two dashed lines. It should be noted that the deficiencies and duplications 




































Chromosome 2 198 ≅ 91% 30 15.15% 
Chromosome 3 201 ≅ 94% 49 24.38% 
Total7 399 ≅92% 79 19.80% 
 
                                                        
4 Percent chromosome coverage was calculated by dividing the total coverage given by black lines and 
by the total length of the chromosome arm (Figures 4.2-4.5). 
5 Total Interacting Deficiencies = the total number of deficiencies that are identified suppressors, 
enhancers or are undefined modifiers of the Atg16B overexpression phenotype. 
6 The Percent Interacting Deletions was calculated by dividing the total interacting deletions by the 
total number of deletions tested. 
7 Total was calculated by adding the numbers from Chromosomes 2 and 3. 
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Figure 4.2: Diagram of the 2L deficiency and duplication map. Deficiencies are illustrated as 
the boxes above of the chromosome and duplications are shown as boxes below the 
chromosome. Black lines indicate the approximate coverage of the duplications and 
deficiencies. The black lines above the chromosome indicate the deficiency coverage was 
approximately 93%. The black line below the chromosome indicates the duplication coverage 
was approximately 92%. Black rectangles indicate the deficiency is a false positive. The class 
false positive is given to any modifier that contains a haplo-insufficient lethal gene, or a 
deletes a Minute region. Light Blue rectangles indicate a moderate suppression. Dark Blue 
indicates a strong suppression. Red rectangles indicate a strong enhancement and orange 
































































































































































































































































































































Figure 4.3: Diagram of the 2R deficiency and duplication map. Deficiencies are illustrated as 
boxes above the chromosome and duplications are shown as boxes below the chromosome. 
Black lines indicate the approximate coverage of the duplications and deficiencies. The black 
lines above the chromosome indicate deficiency coverage was approximately 89%. The black 
lines below the chromosome indicate approximate duplication coverage was 95%. Black 
rectangles indicate that the associated interaction is a false positive. The class false positive is 
given to any modifier that contains a haplo-insufficient lethal gene, or a deletes a Minute 
region. Light Blue rectangles indicate a moderate suppression. Dark Blue indicates a strong 
suppression. Red rectangles indicate a strong enhancement and orange rectangles indicate a 

























































































































































































































































































Figure 4.4: Diagram of the 3L deficiency and duplication map. Deficiencies are illustrated to 
above the chromosome and duplications are shown below the chromosome. Black lines 
indicate the coverage of the duplications and deficiencies. The black lines above the 
chromosome indicate the deficiency coverage was approximately 94%. The black lines below 
the chromosome indicate the duplication coverage was approximately 63%. Black rectangles 
indicate a false positive enhancement. The class false positive is given to any modifier that 
contains a gene that is haplo-insufficient lethal, or a deletes a Minute region. Light Blue 
rectangles indicate a moderate suppression. Dark Blue indicates a strong suppression. Red 
rectangles indicate a strong enhancement and orange rectangles indicate a moderate 



































































































































































































































































































Figure 4.5: Diagram of the 3R deficiency and duplication map. Deficiencies are illustrated as 
the boxes above the chromosome and duplications are shown as boxes below the 
chromosome. Black lines indicate the approximate coverage of the duplications and 
deficiencies. The black lines above the chromosome indicate the deficiency coverage was 
approximately 93%. The line below the chromosome indicates the duplication coverage was 
approximately 16%. Black rectangles indicate the interaction is a false positive. The Class 
false positive is given to any modifier that interacts with pnrGAL4, contains a gene that is 
haplo-insufficient lethal, or a deletes a Minute region. Light Blue rectangles indicate a 
moderate suppression. Dark Blue indicates a strong suppression. Red rectangles indicate a 
strong enhancement and orange rectangles indicate a moderate enhancement. Yellow 














































































































































































































































































































Table 4.3: Strong Suppressors Identified In The Genetic Screen 
Chromosome Aberration (Stock) Cytology Of Dp or Df 
Associated Interacting 
Regions* 
Df(2R)Exel6066 (7548) 53F9; 54B6 53F10; 54B2 
Df(3L)vin7 (2612) 68C8-11; 69B4-5 Conflicting Overlap 
Df(3L)kto2 (3617) 76B1-2; 76D5 Conflicting Overlap 
 
                                                        
* “Conflicting Overlap” indicates there exists another deficiency in the same region that did not exhibit 
an interaction with the Atg16B overexpression phenotype. 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Of Dp or Df 
Associated Interacting 
Regions* 
Df(2L)ED334 (9343) 25F2; 26B2 25F2; 26B1 
Dp(2;2)Cam6 (4518) 35B; 36C 35D1; 35D2 
Df(2L)Exel6039 (7522) 36A10; 36B3 36A10; 36B1 
Dp(2;2)Cam11 (2626) 43B3-C1; 47B10-14 46C7; 46D6 
Df(2R)Exel7130 (7875) 50D4; 50E4 50C9; 50E4 
Df(2R)Exel7149 (7890) 54C10; 54D5 Conflicting Overlap 
Df(2R)BSC22 (6647) 56D7-E3; 56F9-12 56D10; 56F11 
Df(3L)ME107 (4429) 77F3; 78C8-9 78A2; 78C5 
Df(3R)Exel6144 (7623) 83A6; 83B6 83A6 
Df(3R)H-B79 (4962) 92B3; 92F13 Conflicting Overlap 
Df(3R)Exel6195 (7674) 95A4; 95B1 95A4; 95B5 
Df(3R)Exel9013 (7991) 95B1; 95B5 95A4; 95B5 
 
                                                        
*“Conflicting Overlap” indicates there exists another deficiency in the same region that did not exhibit 
an interaction with the Atg16B overexpression phenotype. 
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Of Dp or Df 
Associated Interacting 
Regions* 
Dp(2;2)Cam2 (3394) 23D1-2; 26C1-2 25F2; 26B1 
Df(2L)ED12527 (24129) 28C4; 28D3 28C1; 28E5 
Df(2L)Exel7034 (7807) 28E1; 28F1 28C1; 28E5 
Df(2L)ED784 (7421) 34A4; 34B6 34B4; 34B6 
Df(2R)BSC152 (9539) 46C1; 46D6 46C7; 46D6 
Df(2R)ED2247 (8912) 48A3; 48D5 48B6; 48C5 
Dp(2;3)Cam14T (4519) 49A; 51E-F 50D4; 50E4 
Df(3L)Exel6098 (7577) 63F2; 63F7 Conflicting Overlap 
Df(3L)ZN47 (3096) 64C; 65C 64D6; 64E2 
Dp(3;3)Cam35 (5745) 67C5-11; 69A4-5 68C8-11; 69A4-5 
Df(3L)ED4483 (8070) 69A4; 69D3 69C4; 69D3 
Df(3L)ED229 (8087) 76A1; 76E1 76A5; 76A7 
Df(3R)ED5296 (9338) 84F6; 85C3 85B6; 85C3 
Df(3R)ED5330 (9077) 85A5; 85D1 85B6; 85C3 
Df(3R)by10 (1931) 85D8-12; 85E7-F1 85E1; 85E5 
Df(3R)ED5429 (8919) 85D19; 85F8 85E1; 85E5 
Df(3R)ED5495 (9215) 85F16; 86C7 86B1; 86C3 
Df(3R)ED5591 (9086) 87B7; 87C7 87C3; 88A4 
Df(3R)Tp(3;Y)ry506 85C(1534) 87D1-2; 88E5-6 
87E3; 88A4 
88D7; 88E1 
Df(3R)e-R1 (3340) 93B6-7; 93D2 93B13; 93D2 
Df(3R)Exel6197 (7676) 95D8; 95E1 95D10; 95E1 
Df(3R)ED6187 (9347) 95D10; 96A7 95F7; 96A7 
Df(3R)Exel6202 (7681) 96D1; 96D1 96D1; 96D1 





*“Conflicting Overlap” indicates there exists another deficiency in the same region that did not exhibit 




Table 4.6: Moderate Enhancers Identified In The Genetic Screen.  
Chromosome Aberration 
 (Stock) Cytology Associated Interacting Regions
* 
Dp(2;2)Cam3c (8541) 27C; 27F Conflicting Overlap 
Df(2L)ED508 (8944) 28B1; 28C4 28C1; 28D3 
Df(2L)Exel7043 (7816) 30D1; 30F1 30E4; 30F1 
Df(2L)ED775 (8907) 33B8; 34A3 33C2; 33E9 
Df(2L)BSC340 (24364) 34B4; 34B8 34B6; 34B8 
Df(2L)ED1050 (8946) 35B8; 35D4 35D1; 35D2 
Df(2L)ED1315 (9269) 38B4; 38F5 38C6; 38F3 
Df(3L)ED4287 (8096) 62B4; 62E5 
62D4; 62E1 
62C4; 62D1 
Df(3L)Exel6106 (7585) 64D6; 64E2 64D6; 64E2 
Df(3L)eygC1 (5492) 69A4-5; 69D4-6 69C4; 69D4 
Df(3L)ED4486 (8072) 69C4; 69F6 69C4; 69D4 
Df(3L)Exel6127 (7606) 72D1; 72D9 Conflicting Overlap 
Df(3R)ED5428 (9227) 85E1; 85F8 Conflicting Overlap 
Df(3R)ED5612 (9088) 87C7; 87F6 87E3; 87F6 
Df(3R)ED5623 (8921) 87E3; 88A4 87E3; 87F6 
Df(3R)Exel6173 (7652) 88D7; 88E1 88D7; 88E1 
Df(3R)crb87-5 (2363) 95F7; 96A17-18 95F7; 96A7 
Df(3R)Exel6210 (7688) 98E1; 98F5 98E3; 98F5 
Df(3R)3450 (430) 98E3; 99A6-8 99A5; 99A8 
Df(3R)ED6310 (8961) 98F12; 99B2 99A5; 99A8 
Df(3R)ED6316 (8925) 99A5; 99C1 99A5; 99A8 




* “Conflicting Overlap” indicates there exists another deficiency in the same region that did not exhibit 
an interaction with the Atg16B overexpression phenotype. 
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Df(2L)ED62 (8937) 21D1; 21E2 Conflicting Overlap 
Df(2L)BSC7 (6374) 26D10-E1; 27C1 
26D10-E1; 26F5 
27B1; 27B4 
Df(2L)ED548 (24130) 28E1; 28E9 28E1; 28E5 
Df(2L)BSC241 (9716) 32C1; 32F2 32D2; 32D4 
Df(2L)Exel6027 (7510) 32D2; 32D5 32D2; 32D4 
Df(2L)Exel6045 (7527) 38A3; 38A7 Conflicting Overlap 
Df(2R)BSC630 (25705) 41D3; 41F11 41D3; 41F11 
Df(2R)ED1484 (9683) 42A2; 42A14 42A2; 42A11 
Df(2R)ED1618 (8939) 42C4; 43A1 42C7; 42E1 
Df(2R)BSC40 (7146) 48E1-2; 48E2-10 48E4; 48E10 
Df(2R)BSC383 (24407) 50C6; 50D2 50C18; 50D2 
Df(2R)Exel6071 (7553) 57B3; 57B16 Conflicting Overlap 
Df(2R)Exel6072 (7554) 57B16; 57D4 Conflicting Overlap 
Df(3L)emc-E12 (2577) 61A; 61D3 61A1; 61A5 
Dp(3;3)Cam31 (5743) 61F7-8; 64B10-12 Conflicting Overlap 
Df(3L)Aprt-1 (600) 62A10-B1; 62D2-5 62C4; 62D1 
Df(3L)ED4341 (8060) 63F6; 64B9 Conflicting Overlap 
Df(3L)BSC385 (24409) 62D4; 62E1 62D7; 62E1 
Df(3L)BSC116 (8973) 62D7; 62E5 62D7; 62E1 
Df(3L)Exel8101 (7928) 65A3; 65A9 Conflicting Overlap 
Df(3L)Exel6109 (7588) 65C3; 65D3 Conflicting Overlap 
Df(3L)rdgC-co2 (2052) 77A1; 77D1 Conflicting Overlap 
Df(3R)Exel7315 (7931) 87B8; 87B9 87B9 
Df(3R)Exel7316 (7970) 87B9; 87B11 87B9 
Df(3R)Exel6166 (7645) 87C5; 87C7-8 87C5; 87C7-8 
                                                        
* “Conflicting Overlap” indicates there exists another deficiency in the same region that did not exhibit 
an interaction with the Atg16B overexpression phenotype. 
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After the primary screen was performed, many of the strong interacting deficiencies 
and duplications were tested to ensure that the level of pannier expression was not affected. 
In this experiment, progeny carrying one copy of a strong interacting chromosomal aberration 
and pnrGAL4+UAS-BsgRNAi43307 were compared to siblings carrying pnrGAL4+UAS-
BsgRNAi43307 and a balancer chromosome (for more details see Materials and Methods). The 
[pnrGAL4+UAS-BsgRNAi43307/Df or Dp] or [Df or Dp/+; pnrGAL4+UAS-BsgRNAi43307/+], 
progeny were evaluated based on the severity of the resulting black stripe down the midline of 
the thorax, a novel phenotype associated with RNAi knockdown of Bsg transcripts. The 
intensity and thickness of the black stripe serves here as an indicator of the levels of pannier 
expression. Normally, pnrGAL4+UAS-BsgRNAi43307/+ results in a solid black stripe down the 
thorax (Figure 4.6B). Accordingly, any interactions associated with a decrease in the intensity 
of the black stripe, could indicate a decrease in pannier expression (Figure 4.6A), while an 
increase in the intensity and an extension of the black stripe down the abdomen could indicate 
an increase in pannier expression (Figure 4.6C). Any consistent differences in the black stripe 
phenotype between the balancer and non-balancer groups were considered possible interactors 
with pannier in the screen for chromosomal regions that dominantly interact with Atg16B.  
However, the chromosomal aberrations that result in a change in the intensity and 
thickness of the black stripe could be affecting BsgRNAi43307 and not pannier expression. For 
example, progeny carrying Df(2L)Exel7034 and pnrGAL4+BsgRNAi43307 displayed a strong 
black stripe down the abdomen, indicating an increase pannier expression (Figure 4.6C). 
However, the Df(2L)Exel7034 deficiency deletes the Bsg gene; therefore, it is presumably the 
further decrease in Bsg by the Df that is acting to enhance the knockdown phenotype. 
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Since it is expected that true false positives would disrupt pannier expression no 
matter what the UAS-construct, the same strong interactors were crossed to 
pnrGAL4+EP(3)3614. Normally, the expression of EP(3)3614, under the control of 
pnrGAL4, results in the complete loss of dorso-central and scutellar macrochaetae and 
microchaetae along dorsal midline including the abdomen (Peña-Rangel et al., 2002).     
[pnrGAL4+EP(3)3614/Df or Dp] or [Df or Dp/+; pnrGAL4+EP(3)3614/+] progeny were 
compared to siblings carrying pnrGAL4+EP(3)3614 and a balancer chromosome with respect 
to the severity of the resulting hairless stripe down the midline of the thorax and abdomen (for 
more details see Materials and Methods). Any interactions associated with an increase in the 
number of micro- and macrochaetae along the dorsal midline would indicate a decrease in 
pannier expression, while a lateral expansion of the hairless line phenotype down the dorsal 
midline would indicate an increase in pannier expression (data not shown). Any consistent 
differences in the hairless phenotype between the two groups were considered possible 
interactors with pannier expression (Tables 4.3, 4.5). Afterwards, any deficiency or 
duplication that resulted in an interaction with both UAS-BsgRNAi43307 and EP(3)3614 were 
considered true interactors of pannier expression. 
To date, no interacting deficiency or duplication has interacted with both constructs. 
However, progeny carrying UAS-BsgRNAi43307 and Df(3L)ZN47 displayed a strong black 
stripe down the abdomen. Similarly, progeny carrying Df(3R)Exel6202 and EP(3)3614 
displayed a lateral expansion of the hairless line phenotype down the dorsal midline and were 
semi-lethal. Since these deficiencies resulted in the enhancement of only one of the two 
constructs, their effects are likely due to the interaction with UAS-BsgRNAi43307 or EP(3)3614 
respectively. Therefore these deficiencies are still considered modifiers of the Atg16B 
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overexpression phenotype.  In the future it is hoped that all interacting deficiencies will be 
crossed to the pnrGAL4+UAS-BsgRNAi43307 and pnrGAL4+EP(3)3614 stocks to determine 
whether the levels of pannier expression are affected. 
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Figure 4.6: Stereomicroscopic Imaging of Drosophila expressing UAS-BsgRNAi43307 in 
tissues specified by pnrGAL4. (A) UAS-BsgRNAi43308/+; pnrGAL4/+ Drosophila carrying 
UAS-BsgRNAi43308 on the second chromosome. Image illustrates a decrease in the intensity of 
the black stripe phenotype. Only a small black circle, just above the scutellum, is observed. 
(B) pnrGAL4/UAS-BsgRNAi43307 Drosophila carrying UAS-BsgRNAi43307 on the third 
chromosome. Image illustrates an intermediate black stripe. (C) UAS-BsgRNAi43307+ 
pnrGAL4/ Df(2L)Exel7034 Drosophila carrying UAS-BsgRNAi43307 and a Deficiency on the 
third chromosome. Image illustrates an increase in the severity of the black stripe phenotype. 





























4.2 Target Interacting Regions that dominantly interact with Atg16B 
Of the 44 interacting regions previously identified in the genetic screen, 9 interacting 
regions have been targeted as the best candidates to find dose-sensitive modifiers of Atg16B 
expression (Table 4.8). The following rationale was used to choose these regions. First, a 
region was chosen if it had consistent overlap of three or more interacting deficiencies of a 
similar class (See Table 4.1 for Class descriptions). Second, a region was chosen if it 
encompassed an interacting deficiency with a complementing interacting duplication (Figure 
4.1). Each of these target regions contains a relatively small number of genes (Table 4.8). 
Therefore, in the future, all genes within these 9 promising interacting regions will be tested 
to determine whether they modify the adult cuticular phenotype and whether they promote or 
inhibit autophagy-dependent caspase activation (See Future Directions). It is hoped that some 
of these promising interacting regions will possess genes that are involved with autophagy-
dependent caspase activation. Recently, candidate genes that may be involved in the 
regulation of autophagy-dependent caspase activation have been chosen from the targeted 
interacting regions (Table 4.8). For example, miR-308 was identified in the target region 
50D4; 50E4. Since miRNAs are involved in cell growth and apoptosis (Su et al., 2009), miR-
308 is a strong candidate for the regulation of autophagy-dependent apoptosis. Already, many 
of the candidate genes located within these targeted interacting regions, such as Atg6 and 
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8 “Interacting Regions” column indicates the cytological locations of all deficiencies and duplications 
combined into one interacting region. 
9 “Complimenting Df and Dp” indicates that the class of the deficiency is opposite to that of the 
duplication. “Df Overlap, Similar Class” indicates that all the mentioned deficiencies in that region 
were overlapping and displayed a similar class as given in Table 4.1. 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4.3 Screen For Loci That Dominantly Interact With Atg16B 
Crosses similar to those described in the initial genetic screen were used to identify 
individual loci that exhibit dominant interactions with Atg16B. Candidate genes were chosen 
based on previously identified relationships (Drysdale and Crosby, 2005). For example some 
candidate genes were chosen based on their association with autophagy, autophagic cell death 
or apoptosis. Other genes were chosen because of their involvement in cell adhesion, cell 
cycle, or vesicular transport. Also, some candidate genes were chosen because of their 
involvement in cell signaling pathways such as the JNK or Dpp pathways, which have many 
different functions but are also associated with cell death (Drysdale and Crosby, 2005). 
Mutant alleles of each candidate gene were tested for modification of the thoracic cleft 
and reduced scutellum phenotype (Table 4.8). Any consistent differences based on the 
previously mentioned criteria (Table 4.1) were noted. Out of the 60 mutants, three alleles 
ApcN175K, Apc2Q8 (these two alleles were tested as two separate mutations on the same 
chromosome), and dpphr92 were identified as dominant modifiers of Atg16B expression (Table 
4.8). It is hypothesized that dpphr92 is a good candidate for the modification of Atg16B 
expression, as it does not affect pannier expression when crossed to pnrGal4+BsgRNAi43307 
(data not shown). Also, the undefined modifier phenotype associated with the ApcN175K and 
Apc2Q8 mutant alleles is similar to the corresponding interacting (Df(3R)ED6187, 
Df(3R)Exel6210 and Df(3R)3450) (Tables 4.5, 4.6) deficiencies, indicating that ApcN175K and 
Apc2Q8 may be bona fide dose-sensitive undefined modifiers of the Atg16B overexpression 
phenotype. However, further research must be performed to confirm these results. During this 
screen another allele of dpp, dppH46, resulted in a dominant interaction but was ruled out as it 
is a haplo-insufficient lethal (Table 4.9). Also, the TM6B balancer, in some cases, gave a 
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strong suppression phenotype (data not shown). Since Tubby (Tb) exists as a dominant 
mutation in these TM6B balancer stocks, the Tb mutation, separated from the TM6B balancer 
chromosome, was tested for the modification of the adult cuticular phenotype. As a result, Tb 
did not suppress the Atg16B overexpression adult cuticular phenotype (data not shown). 
Therefore, it is likely that the Tb mutation is not the source of the interaction associated with 
the TM6B balancer chromosome. In the future, further research should be performed to 












Allele Genetic Interaction11 
H46 HI11 
hr92 SU (-) NR12 decapentaplegic (dpp)   (22F1-22F3) No H48 NC 
7 NC 
K16713  thickveins (tkv)  (25D1-25D2) No 04535a NC 
Macroglobulin complement-related (Mcr)   
(28E1-28E3) 
28E1; 28E5 EY07421 NC 
Mkk4   
(85A5) 
No e01485 NC 
polychaetoid (pyd)  
(85B2-85B7)  85B6; 85C3 KG02008 NC 
16 NC 
12 NC Vacuolar H+-ATPase 55kD B subunit (Vha
55)   
(87C2-87C3) 87C3; 88A4 j2E9 NC 
Daughters against dpp (Dad)  
(89E11) 
No j1E4 NC 
Autophagy-specific gene 6 (Atg6) 
(95D10) 95D10; 95E1 00096 NC 
tuberous sclerosis complex 1 (Tsc1) 
(95E1) 95D10; 95E1 f01910 NC 
u-shaped (ush) 
(21E1-21E2) No 2 NC 
dachsous (ds) 
(21E2) No 05142 NC 
Excitatory amino acid transporter 2 (Eaat2)  
(21E2) No e03003 NC 
Autophagy-specific gene 4 (Atg4) 
(21E4) No MB03551 NC 
PNUTS   
(21E2) 
No KG00572 NC 
                                                        
10 If a candidate gene is located within an interacting region the cytology of the interacting region is 
given in the Associated Interacting Regions Column. 
11 All alleles were classified based on the criteria from Table 4.1. E (+) = Moderate enhancer that is 
semi-lethal; E (++) = Strong enhancer that is Lethal; Su (-) = Moderate suppressor; Su (--) = Strong 
suppressor; UM = Undefined Modifier; NC = No Change. 
12 NR is defined as not relevant as it indicates that the gene does not map to a bona fide interacting 
region. HI indicates the allele was haplo-insufficient lethal. 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Hepatocyte growth factor regulated tyrosine 
kinase substrate (Hrs)  
(23A3) 
No D28 NC 
e03803 NC cyclope (cype)  
(25D6) 
No 03771 NC 
KG10174 NC 
k05901 NC vrille (vri) (25D4-25D5) No KG01220 NC 
2 NC midline (mid) 
(25E2) 
No 1 NC 
2 NC Regulator of cyclin A1 (Rca1)  
(27C1) 
No IX NC 
lethal (2) k09022 (l(2)k09022) 
(27C1-27C2) No k09022 NC 
wee   
(27C4) No ES1 NC 
H2  
DN NC cAMP-dependent protein kinase 1 (Pka-C1)   
(30C5) No 
BG02142 NC 
Ced-12 (elmo)  
(33C4) 33C2; 33E9 C06760 NC 
D23D NC 
08323 NC Rab-protein 6 (Rab6)  (33C4) 33C2; 33E9 k13606 NC 
34Ea-6 NC Son of sevenless (Sos)  
(34D1) 
No k05224 NC 
spitz (spi)  
(37F2) No 1 NC 
l1 NC screw (scw) 
(38A1) 
No 5 NC 
05475 NC 
K12405 NC skittles (sktl)  (57B3) No DG24311 NC 
lethal(3)63Eb (Sc2) 
(63F5; 63F6) 
No 05634 NC 
Ubiquitin-63E (Ubi-p63E) 
(63F5) No EY07341 NC 
Ubiquinol-cytochrome c reductase Cytochrome 
c1 (CG4769) 
(64C13) 
No KG05986 NC 
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Uev1a  
(64C13) No DG14805 NC 
k1 NC Kinesin-like protein at 64D (Klp64D) 
(64C13) No n123 NC 
lethal with a checkpoint kinase (lack) 
(54C12-54D1) No KG07014 NC 
belphegor (bor) 
(89B9) No c05496 NC 
7 NC Delta (Dl) 
(92A1-92A2) 
No 9P NC 
Adenomatous polyposis coli tumor suppressor 
homolog 2 (Apc2) 
95E6-95E6 
No N175K* UM()13 
Enhancer of split (E(spl)) 
(96F10) No rv1 NC 
APC-like (Apc) 
(98E5-98E6) 98E3; 98F5 Q8
* UM () 
Darkener of apricot (Doa)  




13A checkmark indicates that the allele showed the same or similar result as its corresponding 
interacting region or deficiency.  
* Both alleles (ApcQ8 and Apc2N175K) were tested together as they exist as two mutations in one stock.  
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Chapter 5. Discussion 
This study has investigated the process of autophagy and its relationship with cell 
death. Through the use of scanning electron microscopy, stereomicroscopic live imaging, and 
confocal microscopy it was demonstrated that ectopic expression of Atg1 kinase activates a 
full autophagic response. This autophagic response results in a marked induction of cell death 
in various tissues throughout development and is associated with an adult cuticular 
phenotype. Using this striking adult cuticular phenotype, a genetic screen was performed with 
the goal of identifying dose-sensitive modifiers of Atg16B expression. The identification of 
these interacting regions is significant, as it will enable the discovery of novel regulators of 
autophagy-dependent caspase activation in Drosophila melanogaster. 
5.1 Evaluating Autophagy Dependent Caspase Activation in the AS 
  The primary objective of this study was to analyze autophagy in AS cells that were 
defective in autophagy or the activation of apoptosis. Upon completion of this objective, the 
following conclusions were made. First, it was demonstrated that autophagy increases prior to 
AS degeneration, and that autophagy is independent of caspase activity. In addition, Atg16B 
overexpression in the AS results in a dramatic increase in autophagy. In a study by Mohseni 
et al., it was shown that this upregulation of autophagy results in the premature elimination of 
the AS, which can be completely suppressed by the co-expression of the caspase inhibitor p35 
(2009). Another conclusion of this thesis was that the activation of the InR/PI3K pathway 
results in a severe decrease in autophagy. Interestingly, it has been shown that the 
downregulation of autophagy, strongly reduces caspase activation, and results in a persistent 
AS phenotype (Reed Lab Unpublished Data; Mohseni et al., 2009). Together, the results of 
this study, along with the results from Mohseni et al., demonstrate that the relationship 
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between autophagy and caspase activation, in the amnioserosa (AS) is epistatic, whereby 
autophagy operates upstream of caspase activation. It was from these experiments that the 
term “autophagy-dependent caspase activation” was created (Mohseni et al., 2009) (Figure 
1.5).  
Similar to studies involving AS degeneration, an epistatic relationship between 
autophagy and caspase activation has been recently demonstrated during Drosophila 
oogenesis (Nezis et al., 2009). Nezis et al. have shown that the increase in autophagy 
observed during development in the germarium and during the mid-stages of oogenesis, is 
followed by caspase activation. Also, in Atg germline mutants, it was shown that there was a 
decrease in the number of cells showing caspase activation and morphological characteristics 
associated with apoptosis. These results suggest that autophagy functions to activate apoptosis 
during oogenesis (2009). In contrast to the previous results, Hou et al. have suggested that 
several genes involved in the activation of apoptosis also function to regulate autophagy 
induced cell death during oogenesis. However, in this case Hou et al. have not confirmed the 
presumed hierarchical relationship between autophagy and caspase activation through 
epistasis experiments (2008). Also, similar to the AS, the study performed by Hou et al., 
supports a model whereby caspases and autophagy function cooperatively during cell death. 
Together, studies of AS degeneration and oogenesis give credence to the argument 
that an epistatic relationship exists between autophagy and apoptosis, however further 
research must be performed to elucidate the mechanisms regulating the activation of both 
PCD pathways. 
101 
5.2 Autophagy Dependent Caspase Activation In the Third Instar Wing 
Disc and Larval Epidermis 
Expanding upon previous findings, autophagy-dependent caspase activation was 
explored in the dorsal larval epidermis. Using Apoliner and a nuclear GFP reporter, it was 
established that the upregulation of autophagy is associated with caspase activity and the 
elimination of cells from the third instar larval epidermis. Also, it was determined that the co-
expression of p35 partially rescues the elimination of Atg16B overexpressing third instar larval 
epidermal cells. These results confirm that autophagy and caspases act cooperatively during 
larval epidermal cell death.  
To further demonstrate that the induction of autophagy induces caspase activation, 
Apoliner was observed in wing discs overexpressing Atg16B. Similar to the AS, the 
overexpression of Atg16B in the proximal area of the third instar wing disc results in an 
increase in autophagosome and autolysosome formation and subsequently caspase-activation. 
 Similar to these results, Scott et al., have demonstrated in patches of the imaginal 
wing disc and fat body that the overexpression of Atg1 results in caspase activation and 
subsequently apoptosis (2007).14 Furthermore, this induction of cell death can be rescued by 
Atg mutant backgrounds, demonstrating the requirement of an intact autophagy pathway for 
the induction of caspases. This study also reported that the co-expression p35 was able to 
delay and reduce the death of Atg1-overexpressing patches in the wing-disc and fat body 
respectively (Scott et al., 2007). Similarly, Atg1 overexpression in the imaginal eye disc 
reduces the overall size of the adult eye in Drosophila (Scott et al., 2007). The ability to 
suppress the reduced eye size phenotype, through the use of caspase inhibitors, indicates that 
                                                        
14 The fat body is a collective name for the sheets of adipose tissue that are distributed throughout the 
fly. This organ is analogous to the vertebrate liver (Jiang et al., 2005). 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the induction of autophagy, above a certain threshold, in the imaginal eye disc results in 
caspase activation and subsequently apoptosis (Scott et al., 2007).  
Together, these results re-enforce that high levels of autophagy induce caspase 
activation. However, before any conclusions are made, the effectiveness of Apoliner as a 
caspase sensor in the third instar wing disc and larval epidermis should be further assessed. In 
the event that Apoliner is a useful tool to detect caspases in the wing disc, the interacting 
deficiencies and duplications that were identified in the genetic screen can be further assessed 
with regards to autophagy-dependent caspase activation (See Future Directions). 
5.3 Stereomicroscopic Live Imaging and Scanning Electron Microscopy: 
Analyzing Cell Death During Metamorphosis 
 Originally, it was hypothesized that the striking adult cuticular phenotype was 
attributable to a process involving autophagy-induced caspase activation. Unfortunately, this 
adult cuticular phenotype could not be rescued through co-expression of the caspase inhibitor 
p35. Therefore, there is no direct correlation between the adult phenotype and autophagy-
dependent caspase activation. However, it was demonstrated, through changes in temperature, 
that the adult cuticular phenotype could be modulated based on Atg16B expression. There are 
several possible explanations for these observations.  
The most promising explanation is that, even though the co-expression of p35 did not 
rescue the adult cuticular phenotype, autophagy above a certain threshold induces the 
execution of apoptosis in these tissues (Section 1.1.2.5 – Figure 1.5). The inhibition of 
executioner caspases, through the ectopic expression of p35, may have been sufficient to 
prevent cell death in the presumptive adult tissues, but resulted in an overgrowth phenotype 
that resembles the adult cuticular phenotype. Previously, Pérez-Garijo et al., have shown that 
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cells undergoing apoptosis in the wing disc emit growth signals. These growth signals induce 
compensatory proliferation in the surrounding surviving cells to restore the normal size of the 
affected tissue. However, “undead cells”, or cells that have initiated but not completed PCD 
due to the inhibition of executioner caspases, continuously emit these growth signals. The 
continuous emission of these growth signals results in large overgrowths and subsequently 
abnormal development (2004). 
Another possibility is that the adult cuticular phenotype is the result of an autophagic 
cell death that is independent of caspase activity (See Section 1.1.2.4 – Figure 1.4). Although 
the following result could be due to incomplete caspase inhibition, it was observed that the 
co-expression of p35 does not rescue the premature cell death of Atg16B overexpressing larval 
epidermal cells during the pre-pupal stages (Figure 3.12 – p35; Atg16B). In a recent study, 
Berry and Baehrecke have demonstrated that the co-expression of p35 in the Drosophila 
salivary gland does not suppress the premature cell death phenotype associated with Atg1 
overexpression (2007). It was concluded in this study that the inability to rescue the Atg1 
overexpression phenotype was due to the cooperative, but parallel, relationship between 
autophagy and apoptosis during salivary gland degeneration (Berry and Baehrecke, 2007; Lee 
and Baehrecke, 2001). However, Berry and Baehrecke may not have achieved complete 
caspase inhibition in the salivary glands. Increasing caspase inhibition, through the co-
expression of two copies of p35 in the salivary glands, may suppress this premature cell 
death. Since Berry and Baehrecke have not established complete caspase inhibition in the 
salivary glands, the only known tissue demonstrating the existence of a caspase-independent 
autophagic cell death, it is questionable whether a bona fide caspase-independent autophagic 
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cell death exists. In summation, it is unlikely that autophagic cell death is the cause of the 
adult cuticular phenotype. 
Another explanation is that the adult cuticular phenotype could be the result of a 
combination of reduced cell growth and increased cell death. It is possible that autophagic 
cells are degrading factors that promote cell growth, preventing the proliferation in the wing 
disc and histoblast nests.  Scott et al., have shown that the overexpression of Atg1 results in a 
marked induction of autophagy and a severe decrease in cell growth in the imaginal eye and 
wing discs and the fat body (2007). Since cells cannot proliferate until they reach a certain 
critical size (Vellai et al., 2008), the eversion and subsequent dorsal movement of the 
proximal area of the wing discs and the dorsal movement of the histoblast nests could be 
prevented when these tissues are autophagic. At the same time, the prolonged induction of 
autophagy, via the overexpression of Atg16B, throughout development could also result in the 
degradation of factors that are required for survival. The degradation of these factors could 
result in the activation of caspases and subsequently apoptosis (Neufeld and Baehrecke, 2008; 
Debnath et al., 2005; Berry and Baehrecke, 2007; McPhee and Baehrecke, 2009). Therefore, 
the ectopic expression of p35 would inhibit the execution of cell death in tissues 
overexpressing Atg16B, but not the resulting growth defects, which could account for the 
inability to rescue the adult cuticular phenotype. 
Lastly, the adult cuticular phenotype may be the result of an inability of autophagic 
cells to secrete adult cuticle along the dorsal midline. Since, a rise in ecdysone is necessary 
for the secretion of adult cuticle in the imaginal discs and abdominal histoblasts (Fristrom and 
Fristrom 1993; Johnson and Milner 1990), it is hypothesized that the induction of autophagy 
either down-regulates protein synthesis or the selectively degrades components involved in 
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ecdysone biosynthesis in these tissues. Such a reduction in ecdysone signaling could inhibit 
the secretion of adult cuticle along the midline of the adult notum and abdomen, resulting in 
the observed prominent clefts and reduced scutellum. Interestingly, it has been shown that the 
overexpression of Atg1 throughout the embryo results in a thin embryonic cuticle (Nilufar 
Mohseni MSc. Thesis, 2007), a phenotype that is frequently observed in embryos that are 
defective in ecdysone biosynthesis (Kozlova and Thummel 2003).  
5.4 Genetic Screen 
 Since altering the level of Atg16B expression, in a temperature dependent fashion, can 
modulate the adult cuticular phenotype, a broad based genetic screen to identify dose-
sensitive modifiers of autophagy, was performed. 79 interacting deficiencies were identified 
that exhibit dose-sensitive interactions with Atg16B. Of the 79 interacting deficiencies, 42 
were dominant enhancers, 24 deficiencies were dominant undefined modifiers, and 13 
deficiencies were dominant suppressors (Figures 4.2-4.5, Tables 4.3-4.7). These interacting 
deficiencies represent 19.80% of the total deficiencies tested (Table 4.2), indicating that the 
screen was effective in identifying deficiencies that are associated with the regulation of 
autophagy.  
 Furthermore, 44 interacting regions were identified based on the 79 interacting 
deficiencies. From these 44 interacting regions, 9 were targeted as good candidates to find 
genes that are dose-sensitive modifiers of Atg16B expression (Table 4.8). These targeted 
regions contain a relatively small number of genes; therefore, all genes within these regions 
will be tested with respect to modulating the adult cuticular phenotype. 
Already 60 alleles representing 39 candidate genes were tested for modification of the 
adult cuticular phenotype (Table 4.9). These candidate genes were chosen because they map 
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to the targeted interacting regions identified by the primary genetic screen or because of 
previously established relationships with autophagy and cell death. Of the 60 alleles, three 
loss-of-function mutants, ApcN175K, Apc2Q8 and dpphr92, resulted in a dominant interaction 
with Atg16B.  
The Apc loss-of-function mutants were identified as undefined modifiers of the Atg16B 
overexpression phenotype. The APC proteins are tumor suppressors that function in the 
negative regulation of Armadillo,15 an integral part of the Wnt/Wingless signaling pathway  
(Ahmed et al., 1993). Therefore, it is speculated in this thesis that autophagic cells in the wing 
disc degrade cytoplasmic Armadillo, reducing the cell’s ability to mediate wingless signaling. 
Under these circumstances, the Apc/Apc2 loss-of-function mutants should result in an 
increase in cytoplasmic Armadillo, restoring the cell’s ability to mediate wingless signaling. If 
this hypothesis is correct, it will be possible to test for suppression of the adult cuticular 
phenotype through the co-expression of UAS-Armadillo.  
The dpphr92 loss-of-function mutant was identified as a dominant moderate suppressor 
of the Atg16B overexpression adult cuticular phenotype. decapentaplegic (dpp) is a secreted 
morphogen that is involved in a variety of processes such as the determination of the dorsal-
ventral axis in the blastoderm embryo, dorsal closure in the embryo, and the patterning of the 
imaginal wing discs (Affolter et al., 2001). It is speculated in this thesis that autophagic cells, 
through some unknown mechanism, upregulate dpp expression in the presumptive adult 
tissues. Under these circumstances, the dpphr92 loss-of-function mutant decreases dpp 
expression, suppressing the adult cuticular phenotype. In the future, in situ hybridization 
                                                        
15 Armadillo is the Drosophila homologue of ß-catenin (Ahmed et al., 1993). 
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experiments can be performed in the wing disc to assess dpp expression in cells 
overexpressing Atg16B.  
In summation, although the mechanisms by which these two genes interact with 
Atg16B are not clear, it is suggested that these two genes function in the regulation of 
autophagy, which is a novel and interesting finding. 
Conclusion 
 There is growing evidence in the field that, in certain contexts, high levels of 
autophagy can induce caspase activation. The precise molecular mechanism by which this 
might occur, however, remains unknown. This thesis has provided evidence towards 
autophagy-dependent caspase activation in the AS, and the third instar larval epidermis and 
wing discs. Also, it is presented in this thesis that the overexpression of Atg16B results in an 
adult cuticular phenotype that cannot be directly attributed to caspase activity. Nonetheless, 
altering the level of Atg16B expression can modulate this adult cuticular phenotype. Therefore, 
the adult cuticular phenotype was used in a genetic screen for dose-sensitive modifiers of the 
regulation of autophagy. In evaluating 92% of the major autosomal chromosomes via 
deficiency and duplication mapping, nine promising regions have been identified as having 
loci that behave as dose-dependent modifiers of Atg16B overexpression. However, further 
screening must be performed to determine which of the interactors are specific to autophagy-
dependent caspase activity.  
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Chapter 6. Future Directions 
The following studies regarding the selective nature of autophagy and its relationship 
with caspase activation will be performed in the near future. 
6.1 Caspase-Activation and Autophagosome Formation In The Wing Disc 
In this study, it was demonstrated that the overexpression of Atg16B in the wing disc 
results in a dramatic increase in autophagy. Also it has been shown that this upregulation of 
autophagy results in the inappropriate cell death of the wing disc, which can be completely 
suppressed by the co-expression of p35. However, further control experiments should be 
performed to ensure that the overexpression of Atg16B, in this context, results in caspase 
activation. First, pnrGal4+UAS-Atg16B/TM6,Tb[GAL80] should be crossed to UAS-Apomut. 
Apomut is a caspase sensor that is identical to Apoliner except that its “caspase sensitive” site 
carries a mutation that inhibits cleavage by caspases (Bardet et al., 2008). Since Apomut 
cannot be cleaved by caspases, the GFP and RFP should remain co-localized and clearly 
visible at the membrane of Atg16B overexpressing imaginal wing disc cells. If GFP 
accumulates in the nucleus, the cleavage observed in previous experiments, due to Atg16B 
overexpression, is not caspase-specific.  Second, caspase activation should be induced in wing 
discs expressing UAS-Apoliner to ensure that the activation of caspases results in the nuclear 
localization of GFP. If Apoliner is a true indicator of caspase-activation in the wing disc, this 
methodology will be used, along with UAS-mCherry-DrAtg8a in a secondary screen for dose-





6.2 Investigate Candidate Deficiencies and Loci Contained within Targeted 
Interacting Regions 
The primary genetic screen identified 9 interacting regions as the regions most likely 
to contain loci that are dose-sensitive modifiers of Atg16B expression (Table 4.8). Therefore, 
in the future, all genes contained within these targeted interacting regions will be tested to 
determine whether they modify the adult cuticular phenotype. Afterwards, any interacting 
genes or deficiencies will be tested in a secondary screen to assess their involvement in 
autophagy-dependent caspase activation.  
In the secondary screen, previously identified interacting deficiencies and genes will 
be crossed separately to UAS-mCherry-DrAtg8a and UAS-Apoliner. The wing discs of the 
resulting progeny that overexpress Atg16B and carry the deficiency or mutation will be 
compared to control wing discs. Any consistent differences between the two groups with 
respect to autophagosome and autolysosome formation (if crossed to UAS-mCherry-DrAtg8a) 
or nuclear localization of GFP (if crossed to UAS-Apoliner), will be used to test the effect of 
the interacting deficiency or mutation on autophagy-dependent caspase activation. 
Afterwards, these interacting genes and deficiencies can be tested in the AS to 
elucidate regulators of developmentally induced autophagy-dependent caspase activation. 
111 
Appendix A. General Background  
112 
Appendix A. General Background 
A.1 The Drosophila Life Cycle 
Under ideal conditions at 25°C, an embryo will develop into an adult fly in 
approximately 9 days (Figure A.1). Normally, 22-24hrs after embryos have been laid (AEL), 
the majority of larvae will hatch from the embryo. Subsequently, larvae will pass through 
three instars in 4 days (Demerec, 1985). The first and second instars last for 24hrs, while the 
third instar lasts for 48 hours. In the late third instar, larvae enter a wandering stage, in which 
larvae leave food and begin searching for a pupariation site. Pupariation, or the formation of 
the puparium, starts approximately 5 days AEL (Figure A.1).  During pupariation, the larval 
body shortens, anterior spiracles evert, and the larval cuticle sclerotinizes to form the pupal 
case (Ashburner, 1989).  After pupariation, pupation occurs. Pupation, the formation of the 
pupae, is the result of apolysis, which is the retraction of the epidermis from the hardened 
cuticle (Ashburner, 1989). Following apolysis, pupae are referred to as pharate adults. The 
duration from pupariation to eclosion is approximately 4 to 4.5 days (Figure A.1B) 
(Ashburner, 1989).  
The time it takes for a fly to develop changes with temperature (Ashburner, 1989). 
Under ideal conditions, at 18°C, an embryo will develop into a fly in approximately 17 to 19 
days (Figure A.1C). Under ideal conditions, at 29°C an embryo will develop into a fly in 
approximately 8 days (Figure A.1A) (Ashburner, 1989).  
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Figure A.1: A diagram demonstrating the life cycle of Drosophila melanogaster. (A) 
Developmental life cycle of Drosophila at 29°C takes about eight days (B) Developmental 
life cycle of Drosophila based on optimal growth conditions at 25°C takes about 9 days.  (C) 
Developmental life cycle of Drosophila at 18°C takes about 17-19 days. In all diagrams the x-
axis indicates the number of days associated with each stage in development during the 
Drosophila life cycle. The pictures above and below the diagrams indicate the developmental 


























A.2 The Amnioserosa - Embryogenesis 
The amnioserosa (AS), an extraembryonic tissue, is eliminated during embryogenesis 
in Drosophila (Reed et al., 2004). The AS plays a pivotal role in guiding major 
morphogenetic movements, including germband retraction and DC (Jacinto and Martin, 2001; 
Reed et al., 2004). During DC 10% of the AS cells are basally extruded from the epithelium 
and undergo apoptosis while the lateral epidermal sheets lengthen along the dorsal-ventral 
axis (Mohseni et al., 2009). Ultimately the lateral epidermal sheets meet and fuse along the 
dorsal midline, internalizing the remaining 90% of AS cells (Figure A.2). Once internalized, 
the AS tissue dissociates en masse and undergoes autophagy-dependent caspase activation 
(Mohseni et al., 2009). It should be noted that the duration of embryogenesis changes with 
respect to temperature. Normally, embryogenesis takes approximately twenty-four hours at 
25°C; however at 18°C embryogenesis takes approximately forty-one hours and fifteen 
minutes, almost doubling the development time. In contrast, development time is almost cut 
in half at 29°C with embryogenesis taking about fifteen hours (Ashburner, 1989). 
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Figure A.2: Process of dorsal closure during embryogenesis. The AS (pink) undergoes 
autophagy-dependent caspase activation and dissociates following a process called dorsal 
closure. This process occurs from 10.5-13 hours AEL at 25°C (Picture adapted from: Agnes 
et al., 1999). 
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A.3 Thorax Closure 
During Drosophila melanogaster pupation, wing imaginal discs, specialized epithelial 
sacs consisting of undifferentiated adult cells, proliferate and undergo regulated cell shape 
changes.  This process of proliferation and cell shape changes results in the eversion and 
subsequent dorsal movement of the proximal area of the opposing wing discs (Figure A.3). 
Ultimately, these two wing discs meet and fuse along the dorsal midline, forming the adult 
notum in a process called thorax closure (Figure A.3). A confocal image illustrating nuclear 
GFP in the proximal area of the third instar wing disc is shown in Figure A.3A. The 
overexpression of Atg16B in the proximal area of the wing disc results in autophagy-dependent 
caspase activation and subsequently a thoracic cleft and reduced scutellum. It is noted that the 
distal areas of the two wing discs evert and proliferate to form the adult wings (Figure A.3).  
In addition, the spreading and fusing of the imaginal discs also results in the 
systematic replacement of larval epidermal tissues (Zeitlinger and Bohmann, 1999).  These 
larval tissues are eliminated by PCD (Agnes et al., 1999). At the end of thorax closure, the 
scutellum forms from a protrusion at the dorsal-posterior end of the fused wing disc, 
completing the development of the notum (Figure A.3) (Zeitlinger and Bohmann, 1999).  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Figure A.3: The formation of the adult notum. (A) Image illustrating the location of the 
imaginal wing disc (blue) in larvae. Next to the larvae is a confocal image of a third instar 
wing disc at 20x magnification. The proximal area of the wing disc (green) will proliferate 
and evert to form the adult notum. The distal area of the wing disc (grey) will proliferate and 
evert to form the adult wing. (The Adult Drosophila  cartoon was  adapted  from  Gilbert, 
2003).  (B) Diagram illustrating the process of thorax closure. The domain of pnrGAL4 
expression is illustrated in purple. Arrows indicate the direction of tissue movement (Picture 











 A.4 Abdomen Development 
Another morphogenetic event that occurs during metamorphosis is abdomen 
development. During abdomen development, histoblasts, adult epidermal precursor cells 
grouped together into multiple nests, increase in volume and subsequently proliferate (Figure 
A.4). As a result, histoblast nests expand and fuse with neighboring nests. Ultimately, 
histoblast nests from the left and right sides of the pharate adult meet and fuse along the 
dorsal and ventral midlines (Figure A.4) (Ninov et al., 2007). Throughout the expansion and 
fusion of histoblast nests, larval epithelial cells are systematically replaced by the imaginal 
histoblasts. These larval epithelial cells are eliminated by PCD (Ninov et al., 2007).  Finally, 
histoblasts differentiate, forming the various structures of the adult abdomen, including 
tendons for muscle attachment and the adult abdominal cuticle (Figure A.4) (Madhavan and 
Madhavan, 1980).  
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Figure A.4: Diagram illustrating the process of abdomen development during metamorphosis. 
The dorsal abdominal histoblasts (green and red) that originate in the embryo proliferate and 
expand during metamorphosis to form the dorsal adult tergites. Ventral imaginal discs (blue 




















A variety of stocks were constructed to perform the experiments in this thesis. In 
particular, extensive genetic crosses were required to build the backgrounds used for the 
manipulation of Atg16B. The crossing schemes used to build the stocks used in this study are 
illustrated in this appendix. 
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Figure B.1: Crosses performed to make the pnrGAL4 + UAS-GFPnls recombinant stock. To 
make the new recombinant stock, virgin females from the w; pnrGAL4/TM6C,Sb,Tb (twi-
lacZ) stock were crossed to males from the w; [UAS-GFPnls]8 stock. In the F1 progeny, Tb+ 
(Tubby+) larvae, expressing GFP in a dorsal stripe down the midline, were selected. Freshly 
eclosed w; pnrGAL4/[UAS-GFPnls]8 virgin females were crossed to yw/w; 
dronc51/TM6UW23-1(Tb, Sb). In the F1 progeny, Tb larvae, expressing GFP in a dorsal stripe, 
were selected.  The resulting pnrGAL4+[UAS-GFPnls]8/TM6UW23-1(Sb,Tb) males from this 
selection were inspected for Stubble (Sb) expression and crossed to Ly/TM3,Sb virgin 
females. In the F1 progeny, Tb+, GFP expressing larvae were selected and allowed to develop. 
From this selection, males and virgin females that were Ly+ and exhibited Sb were selected 
and crossed with each other, resulting in the newly made pnrGAL4+UAS-GFPnls/TM3,Sb 






Figure B.2: Crossing scheme used to make the recombinant pnrGAL4+UAS-Atg16B/TM6,Tb, 
[GAL80] stock that was used in the genetic screen. To make the new recombinant stock, 
virgin females from the pnrGAL4/TM6C,Sb,Tb stock were crossed to males from the UAS-
Atg16B stock. In the F1 progeny, Sb+ or pnrGAL4/UAS-Atg16B virgin females were selected 
and crossed to Ly/TM3,Sb males. In the F1 progeny, a freshly eclosed male that exhibited Sb 
(Stubble), Tb+ (Tubby+), and Ly+, and displayed an Atg16B overexpression phenotype was 
selected and crossed to TM6B[GAL80]OV3,Tb/TM3,Sb. In the F1 progeny, males and virgin 
females were selected that exhibited the Sb+, Tb phenotypes and were propagated as a stock. 









Figure B.3: Crossing scheme used to make the pnrGAL4+UAS-Atg16B+UAS-
Apoliner/TM6[GAL80],Tb and the pnrGal4+UAS-Apoliner/TM3,Sb stocks. These stocks 
were used to evaluate caspase activation in the wing disc, larval epidermis and abdominal 
histoblast nests. Also, in the future this stock will be crossed to interacting deficiencies and 
genes to evaluate caspase activation.  
(1) To make the pnrGAL4+UAS-Atg16B+UAS-Apoliner/TM6[GAL80],Tb stock virgin 
females from the pnrGAL4+UAS-Atg16B/TM6,Tb[GAL80] stock was crossed to males from 
the UAS-Apoliner stock at 18ºC. This cross was performed at 18ºC to increase the viability of 
the progeny overexpressing Atg16B. F1, pnrGAL4+Atg16B/UAS-Apoliner, progeny that were 
Tb+ and expressed GFP, were selected and crossed to the Ly/TM6,Tb stock. In the F1 progeny 
Tb larvae expressing GFP were selected and allowed to develop. Once eclosed, virgin females 
or males exhibiting the Atg16B overexpression phenotype were selected for. (Note: In the adult 
males, Ly was selected for in some cases instead of Tb in adult progeny). As a result only 
pnrGAL4+UAS-Atg16B+UAS-Apoliner/[TM6,Tb or Ly,Sb] flies were selected from this cross 
(Stock #1). These virgin females or males were then crossed to TM3,Sb/TM6,Tb[GAL80] at 
18ºC. The F1 embryonic progeny resulting from this cross were moved to 25ºC and allowed to 
develop into adults. Tb and Sb+ virgin females and males, that did not express GFP and had 
no recognizable Atg16B overexpression phenotype were selected and propagated as a stock.  
(2) To make the pnrGAL4+UAS-Apoliner/TM3,Sb stock, virgin females from the 
pnrGAL4+UAS-Atg16B/TM6,Tb[GAL80] stock was crossed to males from the UAS-Apoliner 
stock at 18ºC. F1, pnrGAL4+Atg16B/UAS-Apoliner, progeny that were Tb+ and expressed GFP 
and Atg16B, were selected and crossed to the Ly/TM6,Tb stock. In the F1 progeny Tb virgin 
females or (Tb or Ly) males that expressed GFP but did not have the Atg16B overexpression 
phenotype were selected (Stock #2). pnrGAL4+UAS-Apoliner/TM6,Tb or Ly, were then 
crossed to TM3,Sb/TM6,Tb[GAL80]. In the F1 progeny, Tb+ virgin females and males that 
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Appendix C. GAL80ts Experiment 
C.1 Gal80ts: Evaluation of Atg16B Overexpression During Development 
 Stereomicroscopic Live imaging and Scanning Electron Microscopy have shown that 
cell death, due to Atg16B overexpression in various tissues specified by pnrGAL4, contributes 
to an autophagy-induced adult cuticular phenotype. However, it is unknown which 
developmental stages or tissues are the most sensitive to Atg16B overexpression. Therefore, 
GAL80ts, a temperature-sensitive protein, was employed to temporally regulate UAS-Atg16B 
during development (Figure C.1A) (Further details can be found in Materials and Methods 
Section). In progeny carrying both GAL80ts and UAS-Atg16B, the viability and adult cuticular 
phenotypes associated with Atg16B overexpression, during various stages of development, 
were assessed (Figure C.1B).  
 As a result, it was determined that turning on Atg16B expression at any point between 
embryogenesis and the early phanerocephalic stages results in a strong thoracic and 
abdominal cleft and an absent scutellum. Also, Atg16B expression, during these stages, was 
largely lethal; therefore, the phenotypes were collected from escaper progeny or dissected 
pharate adults (Figure C.1B). Turning on Atg16B expression during the mid phanerocephalic 
stage onwards results in viable progeny that have a mild thoracic and abdominal cleft and a 
mildly reduced scutellum (Figure C.1B). By the Late phanerocephalic stages, turning on 
Atg16B expression shows no effect as the progeny exhibit a wildtype phenotype (Figure C.1B). 
These results indicate that progeny are most sensitive to Atg16B overexpression from 
embryogenesis to the mid phanerocephalic stages.  
 However, progeny in which Atg16B expression has been turned off by the third instar 
stages exhibit a wildtype phenotype (Figure C.1B). It is not until the pre-pupal stages before 
133 
Atg16B overexpression results in a mild thoracic and abdominal cleft and a slightly reduced 
scutellum. This result demonstrates that these progeny are not sensitive to Atg16B 
overexpression until the pre-pupal stages (Figure C.1B). Interestingly, progeny in which 
Atg16B expression has been turned off between the phanerocephalic and exarate adult stages 
are semi-lethal and exhibit a phenotype in which the notum is very small and lacks a 
scutellum, but has no identifiable thoracic cleft. Also, these progeny possess a strong to 
moderate abdominal cleft. It is likely that the absence of a thoracic cleft is due to a 
developmental delay, allowing wing discs to regenerate after Atg16B expression has been 
turned off.  
Together, these results suggest that the developmental stages most sensitive to Atg16B 
overexpression are the pre-pupal to the mid phanerocephalic stages. Considering that it is 
between the pre-pupal to the mid phanerocephalic stage when both the wing discs and 
histoblast nests grow, divide and fuse with their counterparts (Fristrom and Fristrom, 1993), it 






Figure C.1: Summary Tables: GAL80ts Experiment (A) Summary Table illustrating the 
developmental periods in which Atg16B was expressed. The red boxes indicate the 
developmental periods when Atg16B is being expressed. The white boxes indicate when 
Atg16B expression is turned off. The bottom row of the table indicates the developmental 
period in which Atg16B expression was either turned on or off. The far right column indicates 
the vial number associated with each shift in temperature. This vial number can be compared 
with the vial numbers in Figure B. (B) Summary Table illustrating the resulting adult 
phenotypes associated with Atg16B expression at various developmental periods. The top row 
illustrates all the possible phenotypes associated with the GAL80ts experiment. With 
reference to the thoracic cleft phenotype: (None: Small) refers to a small thorax that does not 
possess a thoracic cleft. (None: Wildtype) refers to a thorax that appears similar to wildtype 
and does not possess a thoracic cleft. The left column indicates the vial number associated 
with the vial numbers in (A). An X was placed in any column where the progeny exhibited 























C.2 Evaluation of Atg1 Overexpression During Development using GAL80ts 
  In the previous section GAL80ts was used to determine the developmental stages or 
tissues that are the most sensitive to Atg16B overexpression. As a result, the developmental 
stages that appear to be the most sensitive to Atg16B overexpression are the pre-pupal to the 
mid phanerocephalic stages, a period in development when both the wing discs and histoblast 
nests are growing, dividing and fusing with their counterparts (Fristrom and Fristrom, 1993).  
However, it should be noted that turning off Atg16B expression between the early 
phanerocephalic and exarate stages of development (Figure C.1 - Vials 18-22), resulted in 
progeny with a phenotype identical to the “undefined modifier” phenotype described in the 
genetic screen (Figure C.1B). These progeny exhibited a notum that had no identifiable cleft 
and an absent scutellum, and possessed a strong to moderate abdominal cleft. This result was 
unexpected since turning on Atg16B expression anywhere between the 1st instar and early 
phanerocephalic stages of development (Figure C.1 - Vials 1 to 6) resulted in flies with strong 
thoracic, abdominal, and scutellar defects. A possible explanation for the absence of a 
thoracic cleft in these progeny is that Atg16B is being turned off earlier than what was 
expected, allowing for compensatory proliferation in the wing disc. During this study it was 
observed that the overexpression of Atg16B results in a marked delay in development (data not 
shown). Therefore, the calculated developmental period in which GAL80ts was turned on may 
have been overestimated, extending the period of time in which Atg16B was turned off before 
eclosion. During this time, surviving cells in the wing disc may have proliferated to 
compensate for the autophagy-induced cell death. In a study by Pérez-Garijo et al., it has been 
demonstrated that after losing 50% of its cells due to apoptosis, wing discs use compensatory 
proliferation to regenerate and form normal adult cuticular structures (2004). However, the 
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compensatory proliferation in the wing disc after autophagy-induced cell death does not result 
in a wildtype phenotype. An obvious explanation for the different final adult cuticular 
phenotypes is that Pérez-Garijo et al., induced apoptosis in the wing disc of third instar larvae 
(2004), whereas this thesis demonstrates the induction of cell death in the larval epidermis 
and wing discs. Also, Atg16B overexpression was not turned off until the pupal stages, giving 
the wing discs in this study less time to regenerate than those observed in the study by Pérez-
Garijo et al. (2004). Together, these results indicate that wing discs are able to undergo 
compensatory proliferation when Atg16B expression has been turned off in the earlier stages of 
pupal development. However, further research should be performed to increase the resolution 
of this experiment before any firm conclusions are drawn.  
C.3 Increasing the Resolution of the GAL80ts Experiment 
 In the future, another GAL80ts experiment will be performed to determine the specific 
stages during development that are the most sensitive to Atg16B overexpression. During this 
experiment crosses will be performed in an identical manner to the previous GAL80ts 
experiment (See Materials and Methods). However, at various time-points during 
development, each vial will be shifted twice, once upwards, from 18°C to 29°C, and once 
downwards, from 29°C to 18°C (Figure C.2). This will result in Atg16B being turned on or off 
during a single stage of development (Figure C.2). Once eclosed, the severity of the thoracic 
cleft and the reduced scutellum phenotype of [GAL80ts]/+; pnrGAL4+UAS-Atg16B/TM2 or 
TM6B progeny will be evaluated. Any consistent difference in the severity of the adult 
cuticular phenotype will indicate, with increased resolution, the developmental stages most 
sensitive to Atg16B overexpression. 
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Figure C.2: Summary diagram illustrating the future GAL80ts experiment. During this 
experiment Atg16B expression will be turned on (red boxes) or off (white boxes) for a single 
developmental stage. The bottom row of the table indicates the developmental period in 
which Atg16B expression was either turned on or off. The far right column indicates the vial 

































 Note: Rows that are shaded in gray are false positives because the deficiencies they 
encompass contain either Haplo-insufficient or Minute loci or they delete the pannier region. 
Also, 2 deficiencies are shaded in yellow and 1 deficiency is shaded in blue because they 
interact with BsgRNAi43307 and EP(3)3614 respectively. 
141 
Table D.1: Deficiency (2L) Stocks  
Deficiency Name  
(Stock) Cytology 
Interaction (Su, En, NC)* 
Severity (+/-) 
Df(2L)ED50001  
(24626) 21A1; 21B1 NC 
Df(2L)ED5878  
(9353) 21B1; 21B3 NC 
Df(2L)ED21  
(9177) 21B3; 21B7 NC 
Df(2L)BSC106  
(8672) 21B7; 21C2 NC 
Df(2L)BSC107  
(8673) 21C2; 21E2 NC 
Df(2L)ED62  
(8937) 21D1; 21E2 UM 
Df(2L)ED80 
(9191) 21E2; 21E2 NC 
Df(2L)Exel7005 
(7775) 21E2; 21E2 NC 
Df(2L)ED6003  
(7490) 21E2; 21E4 NC 
Df(2L)ED94  
(8908) 21E2; 21E3 NC 
Df(2L)ED105 
(24118) 21E2; 22A1 NC 
Df(2L)Exel6004  
(7491) 21E4; 21F1 NC 
Df(2L)ED108  
(24629) 21F1; 22A1 NC 
Df(2L)Exel6005  
(7492) 22A3; 22B1 NC 
Df(2L)Exel7007  
(7778) 22B1; 22B5 NC 
Df(2L)Exel8005 
(7779) 22B2; 22B8 NC 
Df(2L)ED123  
(8943) 22B8; 22D4 NC 
Df(2L)Exel7010  
(7782) 22D4; 22E1 NC 
Df(2L)Exel7011  
(7783) 22E1; 22F3 EN (++) 
                                                        
*All deficiencies were classified based on the criteria from Table 4.1. E (+) = Moderate Enhancer that 
is semi-lethal; E (++) = Strong Enhancer that is lethal; Su (-) = Moderate Suppressor; Su (--) = Strong 
Suppressor; UM = Undefined Modifier; NC = No Change 
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Df(2L)ED136  
(9176) 22F4; 23A3 NC 
Df(2L)Exel6277  
(7744) 23A2; 23B1 NC 
Df(2L)BSC692  
(26544) 23B3; 23B7 UM 
Df(2L)ED4651  
(8904) 23B8; 23F3 NC 
Df(2L)Exel7016  
(7787) 23E5; 23F3 NC 
Df(2L)BSC292  
(23677) 23F6; 24A2 NC 
Df(2L)Exel7018  
(7789) 24A1; 24C2 NC 
Df(2L)Exel6009  
(7495) 24C3; 24C8 NC 
Df(2L)Exel8010  
(7790) 24C8; 24D4 NC 
Df(2L)BSC295  
(23680) 24D4; 24F3 UM 
Df(2L)ED250  
(9270) 24F4; 25A7 NC 
Df(2L)Exel6010  
(7496) 25A7; 25B1 NC 
Df(2L)Exel8012  
(7793) 25B1; 25B5 NC 
Df(2L)Exel7021  
(7795) 25B3; 25B5 NC 
Df(2L)Exel8013  
(7796) 25B5; 25B10 NC 
Df(2L)Exel7022  
(7794) 25B10; 25C3 NC 
Df(2L)BSC110  
(8835) 25C1; 25C4 NC 
Df(2L)BSC109  
(8674) 25C4; 25C8 NC 
Df(2L)Exel6011  
(7497) 25C8; 25D5 EN (++) 
Df(2L)Exel6012  
(7498) 25D5; 25E6 NC 
Df(2L)Exel7023  
(7797) 25E5; 25F1 NC 
Df(2L)Exel8016  
(7798) 25E6; 25F2 NC 
Df(2L)ED334  
(9343) 25F2; 26B2 SU (-) 
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Df(2L)BSC354  
(24378) 26B1; 26B5 NC 
Df(2L)ED384  
(9297) 26B2; 26D7 NC 
Df(2L)BSC7  
(6374) 26D10-E1; 27C1 UM 
Df(2L)Exel7027  
(7801) 26F6; 27B1 NC 
Df(2L)BSC108 
(8847) 27C1; 27C6 NC 
Df(2L)Exel7029  
(7802) 27C4; 27D4 NC 
Df(2L)BSC291  
(23676) 27D6; 27F2 NC 
Df(2L)Exel8019  
(7803) 27E2; 27E4 NC 
Df(2L)Exel6017  
(7503) 27E4; 27F3 NC 
Df(2L)ED489  
(9060) 27E4; 28B1 NC 
Df(2L)Exel6018 
(7504) 28B1; 28C1 NC 
Df(2L)ED508  
(8944) 28B1; 28C4 EN (+) 
Df(2L)ED12527  
(24129) 28C4; 28D3 EN (++) 
Df(2L)Exel7034  
(7807) 28E1; 28F1 EN (++) 
Df(2L)ED548 
(24130) 28E1; 28E9 UM 
Df(2L)BSC228 
(9705) 28E5; 28F4 NC 
Df(2L)BSC227 
(9704) 28E8; 29B1 NC 
Df(2L)ED578 
(24131) 28F1; 29A3 NC 
Df(2L)BSC229  
(9706) 28F1; 29B1 NC 
Df(2L)ED611  
(9298) 29B4; 29C3 NC 
Df(2L)ED623  
(8930) 29C1; 29E4 NC 
Df(2L)ED647  
(8678) 29E1; 29F5 NC 
Df(2L)ED678  
(8906) 29F5; 30B12 NC 
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Df(2L)Exel6024  
(7507) 30C1; 30C9 NC 
Df(2L)ED695  
(8041) 30C5; 30E4 NC 
Df(2L)Exel7043  
(7816) 30D1; 30F1 EN (+) 
Df(2L)BSC205  
(9632) 30F5; 31A2 NC 
Df(2L)Exel8024  
(7817) 31A2; 31B1 NC 
Df(2L)Exel7046  
(7819) 31B1; 31D9 NC 
Df(2L)BSC342   
(24366) 31D9; 31E5 NC 
Df(2L)Exel7048  
(7999) 31E3; 31F5 NC 
Df(2L)ED746  
(8043) 31F4; 32A5 NC 
Df(2L)Exel8026  
(7820) 31F5; 32B3 NC 
Df(2L)Exel7049  
(7821) 32B1; 32C1 NC 
Df(2L)BSC241  
(9716) 32C1; 32F2 UM 
Df(2L)Exel6027  
(7510) 32D2; 32D5 UM 
Df(2L)BSC242 
(24905) 32D4; 32F4 NC 
Df(2L)Exel6028  
(7511) 32D5; 32E4 NC 
Df(2L)Exel6029  
(7512) 32E4; 32F2 NC 
Df(2L)BSC244  
(9718) 32F2; 33B6 NC 
Df(2L)Exel6030  
(7513) 33A2; 33B3 NC 
Df(2L)Exel6031  
(7514) 33B3; 33C2 NC 
Df(2L)ED775  
(8907) 33B8; 34A3 EN (+) 
Df(2L)ED778  
(7420) 33E9; 34A7 NC 
Df(2L)ED784  
(7421) 34A4; 34B6 EN (++) 
Df(2L)BSC340  
(24364) 34B4; 34B8 EN (+) 
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Df(2L)BSC147  
(9506) 34C1; 34C6 NC 
Df(2L)BSC691  
(26543) 34C3; 34D1 NC 
Df(2L)Exel7059  
(7826) 34D1; 34E1 NC 
Df(2L)ED793  
(9061) 34E4; 35B4 NC 
Df(2L)ED3  
(6963) 35B2; 35D1 NC 
Df(2L)ED1050  
(8946) 35B8; 35D4 EN (+) 
Df(2L)Exel7063 
(7831) 35D2; 35D4 NC 
Df(2L)Exel6038  
(7521) 35D6; 35E2 NC 
Df(2L)BSC293  
(23678) 35E1; 35F1 NC 
Df(2L)Exel6039  
(7522) 36A10; 36B3 SU (-) 
Df(2L)Exel8036  
(7835) 36B1; 36C9 NC 
Df(2L)Exel7068  
(7838) 36C7; 36C10 NC 
Df(2L)Exel7069  
(7837) 36C10; 36D3 NC 
Df(2L)Exel7070  
(7839) 36E2; 36E6 NC 
Df(2L)Exel8038  
(7840) 36E5; 36F5 SU (-) 
Df(2L)Exel6041  
(7523) 36F6; 37A2 NC 
Df(2L)ED1203  
(8935) 36F7; 37C5 NC 
Df(2L)ED1231  
(9174) 37C5; 37E3 NC 
Df(2L)ED1303  
(8679) 37E5; 38C6 NC 
Df(2L)Exel6044 
(7526) 37F2; 38A3 NC 
Df(2L)Exel6045 
(7527) 38A3; 38A7 UM 
Df(2L)Exel7077 
(7850) 38A7; 38B2 NC 
Df(2L)ED1315  
(9269) 38B4; 38F5 EN (+) 
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Df(2L)Exel7080  
(7853) 38F3; 39A2 NC 
Df(2L)Exel6047  
(7529) 39A2; 39B4 NC 
Df(2L)Exel6048  
(7530) 39B4; 39C2 NC 
Df(2L)ED1473  
(9266) 39B4; 40A5 NC 
Df(2L)ED1466 
(9340) 39E3; 40A5 NC 
Df(2L)BSC104 
(8670) 39D5; 39E2 NC 
Df(2L)BSC151  






















Table D.2: Deficiency (2R) Stocks 
Deficiency Name  
(Stock) Cytology Interaction (Su, EN, NR)
* 
Df(2R)BSC630  
(25705) 41D3; 41F11 UM 
Df(2R)ED1484  
(9683) 42A2; 42A14 UM 
Df(2R)ED1552  
(8044) 42A11; 42C7 NC 
Df(2R)ED1618  
(8939) 42C4; 43A1 UM 
Df(2R)ED1673  
(9062) 42E1; 43D3 NC 
Df(2R)ED1715  
(8931) 43A4; 43F1 NC 
Df(2R)ED1735  
(9275) 43F8; 44D4 NC 
Df(2R)ED1742  
(9276) 44B8; 44E3 NC 
Df(2R)ED1791  
(9063) 44F7; 45F1 NC 
Df(2R)BSC131  
(9296) 46A1; 46B4 NC 
Df(2R)Exel9016  
(7867) 46B1; 46B2 NC 
Df(2R)BSC298  
(23682) 46B2; 46C7 NC 
Df(2R)BSC152  
(9539) 46C1; 46D6 E (++) 
Df(2R)BSC303  
(23686) 46E1; 46F3 NC 
Df(2R)BSC281  
(23666) 46F1; 47A9 NC 
Df(2R)ED2098 
(9277) 47A7; 47C6 NC 
Df(2R)ED2155  
(9344) 47C6; 47F8 NC 
Df(2R)ED2219  
(8910) 47D6; 48B6 NC 
                                                        
*All deficiencies were classified based on the criteria from Table 4.1. E (+) = Moderate Enhancer that 
is semi-lethal; E (++) = Strong Enhancer that is lethal; Su (-) = Moderate Suppressor; Su (--) = Strong 
Suppressor; UM = Undefined Modifier; NC = No Change 
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Df(2R)ED2247  
(8912) 48A3; 48D5 EN (++) 
Df(2R)BSC199   
(9626) 48C5; 48E4 NC 
Df(2R)BSC40  
(7146) 48E1-2; 48E2-10 UM 
Df(2R)BSC3   
(5879) 48E12-F4; 49A11-B6 UM 
Df(2R)Exel6061  
(7543) 48F1; 49A6 UM 
Df(2R)Exel7121  
(7869) 49B5; 49B12 SU (-) 
Df(2R)ED2308  
(9268) 49C3; 49E7 NC 
Df(2R)Exel8057  
(7871) 49F1; 49F10 NC 
Df(2R)Exel7124  
(7872) 49F10; 50A1 NC 
Df(2R)BSC306   
(23689) 50A3; 50B1 NC 
Df(2R)BSC307  
(23690) 50B6; 50C18 NC 
Df(2R)Exel7128  
(7873) 50C5; 50C9 NC 
Df(2R)BSC383   
(24407) 50C6; 50D2 UM 
Df(2R)Exel7130  
(7875) 50D4; 50E4 SU (-) 
Df(2R)Exel7131  
(7876) 50E4; 50F6 NC 
Df(2R)ED2354  
(8913) 50E6; 51B1 NC 
Df(2R)Exel6284  
(7749) 51B1; 51C2 NC 
Df(2R)BSC429   
(24933) 51C2; 51D1 NC 
Df(2R)BSC651  
(25741) 51C5; 51E2 NC 
Df(2R)ED2426  
(9064) 51E2; 52B1 NC 
Df(2R)ED2436  
(8914) 51F11; 52D11 NC 
Df(2R)ED2457  
(8915) 52D11; 52E7 NC 
Df(2R)Exel9060  
(7885) 52E11; 52F1 NC 
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Df(2R)BSC609  
(25442) 52F6; 53A5 NC 
Df(2R)Exel7142  
(7886) 53B1; 53C4 NC 
Df(2R)Exel7144  
(7888) 53C8; 53D2 NC 
Df(2R)ED3181  
(9213) 53C9; 53F10 NC 
Df(2R)Exel6066  
(7548) 53F8; 54B6 SU (--) 
Df(2R)BSC161   
(9596) 54B2; 54B17 NC 
Df(2R)BSC355  
(24379) 54B16; 54C3 NC 
Df(2R)BSC45  
(7441) 54C8-D1; 54E2-7 NC 
Df(2R)Exel7149  
(7890) 54C10; 54D5 SU (-) 
Df(2R)Exel7150  
(7891) 54E1; 54E9 NC 
Df(2R)ED3610  
(9066) 54F1; 55C8 NC 
Df(2R)Exel6069  
(7551) 56B5; 56C11 NC 
Df(2R)BSC26  
(6866) 56C4; 56D6-10 NC 
Df(2R)BSC22  
(6647) 56D7-E3; 56F9-12 SU (-) 
Df(2R)Exel7162  
(7896) 56F11; 56F16 NC 
Df(2R)BSC701  
(26553) 56F15; 57A9 NC 
Df(2R)Exel6070  
(7552) 57A6; 57B3 NC 
Df(2R)ED3791  
(9267) 57B1; 57D4 NC 
Df(2R)Exel6071 
(7553) 57B3; 57B16 UM 
Df(2R)Exel6072 
(7554) 57B16; 57D4 UM 
Df(2R)Exel6076  
(7556) 57E1; 57F3 NC 
Df(2R)BSC360   
(24384) 57E6; 58A4 NC 
Df(2R)ED3923  
(8942) 57F6; 57F10 NC 
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Df(2R)ED3943  
(9158) 57F10; 58D4 NC 
Df(2R)ED3952  
(9223) 58B10; 58E5 NC 
Df(2R)Exel7173  
(7903) 58D4; 58E5 NC 
Df(2R)BSC598  
(25431) 58F3; 59A1 NC 
Df(2R)Exel6079  
(7559) 59A3; 59B1 NC 
Df(2R)Exel7176  
(7905) 59B4; 59C2 NC 
Df(2R)Exel7177  
(7906) 59C3; 59D2 NC 
Df(2R)Exel7178  
(7908) 59D5; 59D10 NC 
Df(2R)Exel7180  
(7909) 59E3; 59F6 NC 
Df(2R)BSC610  
(25443) 59F6; 60A14 NC 
Df(2R)BSC601  
(25434) 60A9; 60B1 NC 
Df(2R)BSC356  
(24380) 60B8; 60C4 NC 
Df(2R)Exel6082  
(7561) 60C4; 60C7 NC 
Df(2R)ED4065  
(9069) 60C8; 60E8 EN (+) 
Df(2R)BSC608  
(25441) 60E11; 60F2 NC 
Df(2R)ED50004  










Table D.3: Deficiency (3L) Stocks 
Deficiency Name  
(Stock) Cytology Interaction (SU, EN, NR)
* 
Df(3L)emc-E12  
(2577) 61A; 61D3 UM 
Df(3L)ED4079  
(8046) 61A5; 61B1 NC 
Df(3L)ED201  
(8047) 61B1; 61C1 NC 
Df(3L)ED4177  
(8048) 61C1; 61E2 NC 
Df(3L)ED207  
(8053) 61C9; 62A6 NC 
Df(3L)Exel6087  
(7566) 62A2; 62A6 NC 
Df(3L)ED4256  
(8054) 62A3; 62A6 NC 
Df(3L)BSC181  
(9693) 62A11; 62B7 NC 
Df(3L)Aprt-1  
(600) 62A10-B1; 62D2-5 UM 
Df(3L)BSC364 
(24388) 62B4; 62C4 NC 
Df(3L)ED4287  
(8096) 62B4; 62E5 EN (+) 
Df(3L)Exel6089 
(7568) 62D1; 62D4 NC 
Df(3L)BSC385 
(24409) 62D4; 62E1 UM 
Df(3L)BSC116 
(8973) 62D7; 62E5 UM 
Df(3L)BSC23  
(6755) 62E8; 63B5-6 NC 
Df(3L)Exel6091  
(7570) 62E8; 62F5 NC 
Df(3L)Exel6092  
(7571) 62F5; 63A3 NC 
Df(3L)ED4288  
(8057) 63A6; 63B7 NC 
Df(3L)ED4293  
(8058) 63C1; 63C1 NC 
                                                        
* All deficiencies were classified based on the criteria from Table 4.1. E (+) = Moderate Enhancer that 
is semi-lethal; E (++) = Strong Enhancer that is lethal; Su (-) = Moderate Suppressor; Su (--) = Strong 
Suppressor; UM = Undefined Modifier; NC = No Change. 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Df(3L)ED208  
(8059) 63C1; 63F5 NC 
Df(3L)HR119  
(3649) 63C2; 63F7 NC 
Df(3L)GN34  
(463) 63E6-9; 64A8-9 NC 
Df(3L)Exel6098  
(7577) 63F2; 63F7 EN (++) 
Df(3L)ED4341  
(8060) 63F6; 64B9 UM 
Df(3L)GN24  
(3686) 63F6-7; 64C13-15 NC 
Df(3L)ED210  
(8061) 64B9; 64C13 NC 
Df(3L)ZN47  
(3096) 64C; 65C EN (++) 
Df(3L)Exel6104  
(7583) 64C8; 64C13 NC 
Df(3L)Exel6106  
(7585) 64D6; 64E2 EN (+) 
Df(3L)Exel6107  
(7586) 64E5; 64F5 NC 
Df(3L)Exel7210  
(7927) 65A1; 65A5 NC 
Df(3L)XDI98  
(4393) 65A2; 65E1 NC 
Df(3L)Exel8101  
(7928) 65A3; 65A9 UM 
Df(3L)ED211  
(8063) 65A9; 65B4 NC 
Df(3L)Exel6109  
(7588) 65C3; 65D3 UM 
Df(3L)BSC27  
(6867) 65D4-5; 65E4-6 NC 
Df(3L)Exel6110 
(7589) 65E3; 65E5 NC 
Df(3L)BSC33  
(6964) 65E10-F1; 65F2-6 NC 
Df(3L)pbl-X1  
(1420) 65F3; 66B10 NC 
Df(3L)Exel8104 
(7929) 65F7; 66A4 NC 
Df(3L)Exel6279  
(7745) 66A17; 66B5 NC 
Df(3L)Exel6112  
(7591) 66B5; 66C8 NC 
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Df(3L)BSC13  
(6460) 66B12-C1; 66D2-4 NC 
Df(3L)h-i22  
(3024) 66D10-11; 66E1-2 NC 
Df(3L)ED4421  
(8066) 66D12; 67B3 NC 
Df(3L)AC1  
(997) 67A2; 67D11-13 NC 
Df(3L)Exel6114  
(7593) 67B11; 67C5 NC 
Df(3L)BSC283  
(23668) 67C7; 67D5 NC 
Df(3L)Exel9048  
(7933) 67D1; 67D2 NC 
Df(3L)ED4457  
(9355) 67E2; 68A7 NC 
Df(3L)ED4470  
(8068) 68A6; 68E1 NC 
Df(3L)vin7  
(2612) 68C8-11; 69B4-5 SU (--) 
Df(3L)ED4475  
(8069) 68C13; 69B4 NC 
Df(3L)ED4483  
(8070) 69A5; 69D3 EN (++) 
Df(3L)eygC1  
(5492) 69A4-5; 69D4-6 EN (+) 
Df(3L)ED4486  
(8072) 69C4; 69F6 EN (+) 
Df(3L)BSC10  
(6456) 69D4-5; 69F5-7 NC 
Df(3L)BSC12  
(6457) 69F6-70A1; 70A1-2 NC 
Df(3L)ED4502  
(8097) 70A3; 70C10 NC 
Df(3L)ED4543  
(8073) 70C6; 70F4 NC 
Df(3L)fz-M21  
(3126) 70D2-3; 71E4-5 NC 
Df(3L)ED217  
(8074) 70F4; 71E1 NC 
Df(3L)XG5  
(6551) 71C2-3; 72B1-C1 NC 
Df(3L)brm11  
(3640) 71F1-4; 72D1-10 NC 
Df(3L)st-f13  
(2993) 72C1-D1; 73A3-4 NC 
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Df(3L)Exel6127  
(7606) 72D1; 72D9 EN (+) 
Df(3L)ED4674  
(8098) 73B5; 73E5 NC 
Df(3L)ED4685  
(8099) 73D5; 74E2 NC 
Df(3L)ED4710  
(8100) 74D1; 75B11 NC 
Df(3L)ED224  
(8080) 75B1; 75C6 NC 
Df(3L)Cat  
(2990) 75B8; 75F1 NC 
Df(3L)H99 
(1576) 75C1; 75C2 NC 
Df(3L)ED225  
(8081) 75C1; 75D4 NC 
Df(3L)ED4782  
(8082) 75F2; 76A1 NC 
Df(3L)ED4786  
(8083) 75F7; 76A5 NC 
Df(3L)fz2  
(6754) 75F10-11; 76A1-5 NC 
Df(3L)ED229  
(8087) 76A1; 76E1 E (++) 
Df(3L)BSC20  
(6646) 76A7-B1; 76B4-5 NC 
Df(3L)kto2  
(3617) 76B2; 76D5 SU (--) 
Df(3L)XS533 
(5126) 76B4; 77B NC 
Df(3L)ED4858  
(8088) 76D3; 77C1 NC 
Df(3L)rdgC-co2  
(2052) 77A1; 77D1 UM 
Df(3L)Exel6136  
(7615) 77B2; 77C6 NC 
Df(3L)ri-79c  
(3127) 77B-C; 77F-78A NC 
Df(3L)ri-XT1  
(5878) 77E2-4; 78A2-4 NC 
Df(3L)ME107  
(4429) 77F3; 78C8-9 SU (-) 
Df(3L)Pc-2q  
(4430) 78C5-6; 78E3-79A1 NC 
Df(3L)ED4978  
(8101) 78D5; 79A2 NC 
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Df(3L)Exel6137  
(7616) 78F4; 79A4 NC 
Df(3L)BSC223  
(9700) 79A3; 79B3 NC 
Df(3L)BSC249  
(23149) 79B2; 79D1 NC 
Df(3L)ED230  
(8089) 79C2; 80A4 NC 
Df(3L)ED5017  























Table D.4: Deficiency (3R) Stocks  
Deficiency Name  
(Stock) Cytology Interaction (SU, EN, NR)
* 
Df(3R)ME15 
(1518) 81F3-6; 82F5-7 NC 
Df(3R)ED5046  
(9197) 81F6; 82D2 NC 
Df(3R)3-4  
(4787) 82F3-4; 82F10-11 NC 
Df(3R)ED5156  
(8965) 82F8; 83A4 NC 
Df(3R)ED10257 
(9159) 83A7; 83B4 NC 
Df(3R)ED5177 
(8103) 83B4; 83B6 NC 
Df(3R)Exel6144 
(7623) 83A6; 83B6 SU (-) 
Df(3R)ED5197 
(9339) 83B7; 83D2 NC 
Df(3R)ED7665 
(8685) 84B4; 84E11 EN (+) 
Df(3R)Exel6146 
(7625) 84C8; 84D9 NC 
Df(3R)ED5223 
(9076) 84D9; 84E11 NC 
Df(3R)ED5230 
(8682) 84E6; 85A5 NC 
Df(3R)ED5296 
(9338) 84F6; 85C3 EN (++) 
Df(3R)Exel8143 
(7954) 85A5; 85B2-3 NC 
Df(3R)Exel6150 
(7629) 85A5; 85B6 NC 
Df(3R)ED5330 
(9077) 85A5; 85D1 EN (++) 
Df(3R)by10 
(1931) 85D8-12; 85E7-F1 EN (++) 
Df(3R)ED5429 
(8919) 85D19; 85F8 EN (++) 
Df(3R)ED5428 
(9227) 85E1; 85F8 EN (+) 
                                                        
* All deficiencies were classified based on the criteria from Table 4.1. E (+) = Moderate Enhancer that 
is semi-lethal; E (++) = Strong Enhancer that is lethal; Su (-) = Moderate Suppressor; Su (--) = Strong 
Suppressor; UM = Undefined Modifier; NC = No Change.  
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Df(3R)ED5454 
(9080) 85E5; 85F12 NC 
Df(3R)ED5474  
(9082) 85F11; 86B1 NC 
Df(3R)ED5495 
(9215) 85F16; 86C7 E (++) 
Df(3R)Exel6159 
(7638) 86C3; 86C7 NC 
Df(3R)ED5518 
(9084) 
86C7; 86E13 NC 
Df(3R)ED5559 
(8920) 
86E11; 87B11 NC 
Df(3R)Exel7314 
(7969) 
87B3; 87B8 NC 
Df(3R)ED5591 
(9086) 
87B7; 87C7 EN (++) 
Df(3R)Exel7315 
(7931) 
87B8; 87B9 UM 
Df(3R)Exel7316 
(7970) 
87B9; 87B11 UM 
Df(3R)Exel7317 
(7932) 
87B10; 87C3 NC 
Df(3R)Exel6166 
(7645) 
87C5; 87C7-8 UM 
Df(3R)ED5612 
(9088) 
87C7; 87F6 EN (+) 
Df(3R)Tp(3;Y)ry506-85C 
(1534) 
87D1-2; 88E5-6 EN (++) 
Df(3R)ED5623 
(8921) 
87E3; 88A4 EN (+) 
Df(3R)ED5644 
(9090) 
88A4; 88C9 NC 
Df(3R)Exel8160 
(7978) 
88C10; 88D6 NC 
Df(3R)Exel6173 
(7652) 
88D7; 88E1 EN (+) 
Df(3R)ea 
(383) 
88E7-13; 89A1 NC 
Df(3R)ED5705 
(9152) 
88E12; 89A5 NC 
Df(3R)Exel7326 
(7980) 
88F7; 89A5-6 NC 
Df(3R)sbd105 
(756) 
88F9-89A1; 89B9-10 pannier located here 
Df(3R)BSC569 
(25670) 




89A5; 89A8 NC 
Df(3R)Exel7327 
(7982) 
89A8; 89B1 pannier located here 
Df(3R)Exel7328 
(7983) 
89A12; 89B6 pannier located here 
Df(3R)sbd104 
(1920) 
89B5; 89C2-7 NC 
Df(3R)Exel7329 
(7984) 
89B9; 89B13 NC 
Df(3R)Exel6269 
(7736) 
89B12; 89B18 NC 
Df(3R)Exel6270 
(7737) 
89B18; 89D8 NC 
Df(3R)P115 
(1467) 
89B7-8; 89E7 NC 
Df(3R)DG2 
(4431) 
89E1-F4; 91B1-B2 NC 
Df(3R)Exel8165 
(7988) 
89E8; 89E11 NC 
Df(3R)ED5780 
(8104) 
89E11; 90C1 NC 
Df(3R)Exel6176 
(7655) 
89E11; 89F1 NC 
Df(3R)BSC684 
(26536) 
90A6; 90B7 NC 
Df(3R)ED5815 
(9208) 
90F4; 91B8 NC 
Df(3R)Cha7 
(3011) 
90F1-F4; 91F5 NC 
Df(3R)ED2 
(6962) 
91A5; 91F1 NC 
Df(3R)Exel6183 
(7662) 
91E4; 91F4 NC 
Df(3R)D1-BX12 
(3012) 
91F1-2; 92D3-6 NC 
Df(3R)Exel6184 
(7663) 
92A5; 92A11 NC 
Df(3R)ED6025 
(8964) 
92A11; 92E2 NC 
Df(3R)H-B79 
(4962) 
92B3; 92F13 SU (-) 
Df(3R)Exel6185 
(7664) 
92E2; 92F1 NC 
Df(3R)Exel6272 
(7739) 




93B6-7; 93D2 EN (++) 
Df(3R)ED6076 
(8962) 
93E10; 94A1 NC 
Df(3R)ED6090 
(9091) 
94A1; 94C1 NC 
Df(3R)ED6096 
(8684) 
94B5; 94E7 NC 
Df(3R)BSC56 
(8583) 
94E1-2; 94F1-2 NC 
Df(3R)Exel6274 
(7741) 
94E4; 94E11 NC 
Df(3R)Exel9012 
(7990) 
94E9; 94E13 NC 
Df(3R)Exel6194 
(7673) 
94F1; 95A4 NC 
Df(3R)Exel6195 
(7674) 
95A4; 95B1 SU (-) 
Df(3R)Exel9013 
(7991) 
95B1; 95B5 SU (-) 
Df(3R)Exel9014 
(7992) 
95B1; 95D1 NC 
Df(3R)Exel6196 
(7675) 
95C12; 95D8 NC 
Df(3R)Exel6197 
(7676) 
95D8; 95E1 EN (++) 
Df(3R)ED6187 
(9347) 
95D10; 96A7 EN (++) 
Df(3R)crb87-5 
(2363) 
95F7; 96A17-18 EN (+) 
Df(3R)ED6220 
(9211) 
96A7; 96C3 NC 
Df(3R)Exel6202 
(7681) 
96D1; 96D1 EN (++) 
Df(3R)BSC522 
(25050) 
96D1; 96E3 EN (++) 
Df(3R)Exel6203 
(7682) 
96E2; 96E6 NC 
Df(3R)BSC140 
(9500) 
96F1; 96F10 NC 
Df(3R)Exel6204 
(7683) 
96F9; 97A6 NC 
Df(3R)ED6232 
(8105) 
96F10; 97D2 NC 
Df(3R)ED6255  
(9210) 




97E2; 98A7 NC 
Df(3R)IR16 
(9529) 
97F1-2; 98A NC 
Df(3R)BSC42 
(7412) 
98B1-2; 98B3-5 NC 
Df(3R)Exel6259 
(7726) 
98C4; 98D6 NC 
Df(3R)Exel6209 
(7687) 
98D6; 98E1 NC 
Df(3R)Exel6210 
(7688) 
98E1; 98F5 EN (+) 
Df(3R)Exel6211 
(7689) 
98F5; 98F6 NC 
Df(3R)3450 
(430) 
98E3; 99A6-8 EN (+) 
Df(3R)ED6310 
(8961) 
98F12; 99B2 EN (+) 
Df(3R)ED6316 
(8925) 
99A5; 99C1 EN (+) 
Df(3R)BSC547 
(25075) 
99B5; 99C2 NC 
Df(3R)Exel6213 
(7691) 
99C5; 99D1 NC 
Df(3R)B81 
(3546) 
99D3; 3Rt NC 
Df(3R)Exel6214 
(7692) 
99D5; 99E2 NC 
Df(3R)Exel6215 
(7693) 
99F6-7; 99F8 EN (+) 
Df(3R)Exel7378 
(7997) 
99F8; 100A5 NC 
Df(3R)Exel8194 
(7918) 
100A4; 100A7 NC 
Df(3R)Exel7379 
(7919) 
100B2; 100B5-8 NC 
Df(3R)Exel6218  
(7696) 
100B5; 100C1 NC 
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Table D.5: Duplications Located On The 2nd Chromosome 
Duplication Name  
(Stock) Cytology Interaction (SU, EN, NR)
* 
Dp(2;2)Cam1 
(3392) 21E2; 23D1-2 NC 
Dp(2;2)Cam2 
(3394) 23D1-2; 26C1-2 EN (++) 
Dp(2;2)Cam3a 
(8539) 26C; 27D NC 
Dp(2;2)Cam3 
(3401) 26C1-2; 29F NC 
Dp(2;2)Cam3c 
(8541) 27C; 27F EN (+) 
Dp(2;2)Cam3b 
(8540) 27F; 29F NC 
Dp(2;2)Cam4 
(3403) 29F; 32F NC 
Dp(2;2)Cam5 
(4521) 32E; 35B NC 
Dp(2;2)Cam6 
(4518) 35B; 36C SU (-) 
Dp(2;2)Cam8 
(2630) 36C; 40 NC 
Dp(2;2)Cam10 
(4520) 41; 43B NC 
Dp(2;2)Cam11 
(2626) 43B3-C1; 47B10-14 SU (-) 
Dp(2;2)Cam13 
(3391) 47B10-14; 48C6-8 NC 
Dp(2;2)Cam14T 
(4519) 49A; 51EF EN (++) 
Dp(2;2)Cam12a 
(8542) 51F11-12; 52D5 NC 
Dp(2;2)Cam17 
(4744) 52D10-E1; 53F NC 
Dp(2;2)Cam18 
(4745) 53F1-4; 57C4-6 NC 
Dp(2;2)Cam16 
(2622) 57C4-6; 60E4 NC 
 
                                                        
* All duplications were classified based on the criteria from Table 4.1. E (+) = Moderate Enhancer that 
is semi-lethal; E (++) = Strong Enhancer that is lethal; Su (-) = Moderate Suppressor; Su (--) = Strong 
Suppressor; UM = Undefined Modifier; NC = No Change. 
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Table D.6: Duplications Located On The 3rd Chromosome  
Duplication Name  
(Stock) Cytology Interaction (SU, EN, NR)
* 
Dp(3;3)Cam31 
(5743) 61F7-8; 64B10-12 UM 
Dp(3;3)Cam32 
(5744) 64B10-12; 64E5-9 NC 
Dp(3;3)Cam34 
(8543) 65C5-9; 67C5-11 NC 
Dp(3;3)Cam35 
(5745) 67C5-11; 69A4-5 EN (++) 
Dp(3;3)Cam36 
(5746) 69A4-5; 70F1-2 NC 
Dp(3;3)Cam37 
(5747) 70F1-2; 73C3-D7 NC 
Dp(3;3)Cam30T 









*All duplications were classified based on the criteria from Table 4.1. E (+) = Moderate Enhancer that 
is semi-lethal; E (++) = Strong Enhancer that is lethal; Su (-) = Moderate Suppressor; Su (--) = Strong 
Suppressor; UM = Undefined Modifier; NC = No Change. 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Appendix E. Letters of Copyright Permission 
Dear, Dr. Daniel J. Klionsky 
 My name is Stephanie McMillan, and I am an author on a paper that has recently been 
published in Autophagy. As I am currently finishing my Masters, I would like to ask 
permission to publish some of the data from this paper, in particular the lysotracker data, in 
my Masters thesis. The reference from the paper is as follows: 
Mohseni, N., McMillan, S.C., Chaudhary, R., Mok, J., Reed, B.H., 2009. Autophagy 






You have permission to publish these data. You simply need to cite the original article. 
Dan 
 
Dear, Dr. Daniel Klionsky, 
 Hello, my name is Stephanie McMillan, and I am an author on a paper that has 
recently been published in Autophagy. Recently I requested permission to publish some of 
my data (that has also been published in Autophagy) in my Masters thesis. Although I have 
received permission in the past, the journal should also be informed that I am signing a 
Theses Non-Exclusive License to publish my thesis in "Library and Archives Canada". Also, 
I must receive written acknowledgement from the editor that I have permission to do this. 




You have permission to publish your thesis containing the article from Autophagy in "Library 
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